<abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:dn="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85017529486</prism:url><dc:identifier>SCOPUS_ID:85017529486</dc:identifier><eid>2-s2.0-85017529486</eid><prism:doi>10.18632/oncotarget.15914</prism:doi><dc:title>High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patients</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><citedby-count>0</citedby-count><prism:publicationName>Oncotarget</prism:publicationName><dc:publisher> Impact Journals LLC editors@impactaging.com </dc:publisher><source-id>19900191708</source-id><prism:issn>19492553</prism:issn><prism:volume>8</prism:volume><prism:issueIdentifier>15</prism:issueIdentifier><prism:startingPage>25384</prism:startingPage><prism:endingPage>25394</prism:endingPage><prism:pageRange>25384-25394</prism:pageRange><prism:coverDate>2017-01-01</prism:coverDate><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag><dc:creator><author seq="1" auid="55241121900"><ce:initials>A.</ce:initials><ce:indexed-name>Koren A.</ce:indexed-name><ce:surname>Koren</ce:surname><ce:given-name>Ana</ce:given-name><preferred-name><ce:initials>A.</ce:initials><ce:indexed-name>Koren A.</ce:indexed-name><ce:surname>Koren</ce:surname><ce:given-name>Ana</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/55241121900</author-url><affiliation id="60078312" href="https://api.elsevier.com/content/affiliation/affiliation_id/60078312"/></author></dc:creator><dc:description><abstract xmlns="" original="y" xml:lang="eng"> <ce:para>Polycomb group member protein BMI1 is involved in maintaining cell identity, proliferation, differentiation and human oncogenesis. In the present study, we determined BMI1 mRNA expression in whole blood and evaluated the impact of the expression level on the treatment response and survival of 96 advanced NSCLC patients treated with first-line platinum-based chemotherapy. We also determined BMI1 mRNA expression in primary tumors from 22 operable NSCLC patients treated with radical surgery. We found that compared with control subjects, BMI1 mRNA expression in whole blood of advanced NSCLC patients was decreased (P &lt; 0.001). Similarly, we observed decreased BMI1 mRNA expression in primary tumors compared to normal lungs from operable NSCLC patients (P=0.001). We found high BMI1 mRNA expression in blood was associated with longer progression-free survival (PFS) (P=0.049) and overall survival (OS) (P=0.012) in advanced NSCLC patients treated with first-line platinum-based chemotherapy. However, no association between the BMI1 mRNA level and response to chemotherapy was found (P=0.21). Multivariate Cox proportional hazards regression analysis showed elevated BMI1 mRNA level in whole blood was an independent prognostic factor for longer PFS (P=0.012) and OS (P &lt; 0.001). In conclusion, BMI1 mRNA expression in whole blood might represent a new biomarker for the diagnosis and prognosis of NSCLC.</ce:para> </abstract></dc:description><link href="https://api.elsevier.com/content/abstract/scopus_id/85017529486" rel="self"/><link href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85017529486&amp;origin=inward" rel="scopus"/><link href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85017529486&amp;origin=inward" rel="scopus-citedby"/></coredata><affiliation id="60078312" href="https://api.elsevier.com/content/affiliation/affiliation_id/60078312"><affilname>Bolnišnica Golnik</affilname><affiliation-city>Golnik</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><affiliation id="60031106" href="https://api.elsevier.com/content/affiliation/affiliation_id/60031106"><affilname>University of Ljubljana</affilname><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><affiliation id="60000966" href="https://api.elsevier.com/content/affiliation/affiliation_id/60000966"><affilname>Onkološki inštitut Ljubljana</affilname><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><authors><author seq="1" auid="55241121900"><ce:initials>A.</ce:initials><ce:indexed-name>Koren A.</ce:indexed-name><ce:surname>Koren</ce:surname><ce:given-name>Ana</ce:given-name><preferred-name><ce:initials>A.</ce:initials><ce:indexed-name>Koren A.</ce:indexed-name><ce:surname>Koren</ce:surname><ce:given-name>Ana</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/55241121900</author-url><affiliation id="60078312" href="https://api.elsevier.com/content/affiliation/affiliation_id/60078312"/></author><author seq="2" auid="36939704200"><ce:initials>M.</ce:initials><ce:indexed-name>Rijavec M.</ce:indexed-name><ce:surname>Rijavec</ce:surname><ce:given-name>Matija</ce:given-name><preferred-name><ce:initials>M.</ce:initials><ce:indexed-name>Rijavec M.</ce:indexed-name><ce:surname>Rijavec</ce:surname><ce:given-name>Matija</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/36939704200</author-url><affiliation id="60078312" href="https://api.elsevier.com/content/affiliation/affiliation_id/60078312"/></author><author seq="3" auid="36992707400"><ce:initials>E.</ce:initials><ce:indexed-name>Sodja E.</ce:indexed-name><ce:surname>Sodja</ce:surname><ce:given-name>Eva</ce:given-name><preferred-name><ce:initials>E.</ce:initials><ce:indexed-name>Sodja E.</ce:indexed-name><ce:surname>Sodja</ce:surname><ce:given-name>Eva</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/36992707400</author-url><affiliation id="60078312" href="https://api.elsevier.com/content/affiliation/affiliation_id/60078312"/></author><author seq="4" auid="7003295818"><ce:initials>I.</ce:initials><ce:indexed-name>Kern I.</ce:indexed-name><ce:surname>Kern</ce:surname><ce:given-name>Izidor</ce:given-name><preferred-name><ce:initials>I.</ce:initials><ce:indexed-name>Kern I.</ce:indexed-name><ce:surname>Kern</ce:surname><ce:given-name>Izidor</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7003295818</author-url><affiliation id="60078312" href="https://api.elsevier.com/content/affiliation/affiliation_id/60078312"/></author><author seq="5" auid="55883901600"><ce:initials>A.</ce:initials><ce:indexed-name>Sadikov A.</ce:indexed-name><ce:surname>Sadikov</ce:surname><ce:given-name>Aleksander</ce:given-name><preferred-name><ce:initials>A.</ce:initials><ce:indexed-name>Sadikov A.</ce:indexed-name><ce:surname>Sadikov</ce:surname><ce:given-name>Aleksander</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/55883901600</author-url><affiliation id="60031106" href="https://api.elsevier.com/content/affiliation/affiliation_id/60031106"/></author><author seq="6" auid="7005444734"><ce:initials>V.</ce:initials><ce:indexed-name>Kovac V.</ce:indexed-name><ce:surname>Kovac</ce:surname><ce:given-name>Viljem</ce:given-name><preferred-name><ce:initials>V.</ce:initials><ce:indexed-name>Kovac V.</ce:indexed-name><ce:surname>Kovac</ce:surname><ce:given-name>Viljem</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7005444734</author-url><affiliation id="60000966" href="https://api.elsevier.com/content/affiliation/affiliation_id/60000966"/></author><author seq="7" auid="6701584602"><ce:initials>P.</ce:initials><ce:indexed-name>Korosec P.</ce:indexed-name><ce:surname>Korosec</ce:surname><ce:given-name>Peter</ce:given-name><preferred-name><ce:initials>P.</ce:initials><ce:indexed-name>Korosec P.</ce:indexed-name><ce:surname>Korosec</ce:surname><ce:given-name>Peter</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/6701584602</author-url><affiliation id="60078312" href="https://api.elsevier.com/content/affiliation/affiliation_id/60078312"/></author><author seq="8" auid="7004393140"><ce:initials>T.</ce:initials><ce:indexed-name>Cufer T.</ce:indexed-name><ce:surname>Cufer</ce:surname><ce:given-name>Tanja</ce:given-name><preferred-name><ce:initials>T.</ce:initials><ce:indexed-name>Cufer T.</ce:indexed-name><ce:surname>Cufer</ce:surname><ce:given-name>Tanja</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7004393140</author-url><affiliation id="60078312" href="https://api.elsevier.com/content/affiliation/affiliation_id/60078312"/></author></authors><language xml:lang="eng"/><authkeywords><author-keyword>BMI1</author-keyword><author-keyword>MRNA expression</author-keyword><author-keyword>Non-small cell lung cancer</author-keyword><author-keyword>Peripheral whole blood</author-keyword><author-keyword>Prognosis</author-keyword></authkeywords><idxterms/><subject-areas><subject-area code="2730" abbrev="MEDI">Oncology</subject-area></subject-areas><item xmlns=""><xocs:meta><xocs:funding-list has-funding-info="1" pui-match="primary"><xocs:funding-addon-generated-timestamp>2017-11-17T02:33:51.760Z</xocs:funding-addon-generated-timestamp></xocs:funding-list></xocs:meta><ait:process-info><ait:date-delivered day="30" month="10" timestamp="2017-10-30T05:21:15.000015-04:00" year="2017"/><ait:date-sort day="01" month="01" year="2017"/><ait:status stage="S300" state="update" type="core"/></ait:process-info><bibrecord><item-info><copyright type="Elsevier">Copyright 2017 Elsevier B.V., All rights reserved.</copyright><itemidlist> <ce:doi>10.18632/oncotarget.15914</ce:doi> <itemid idtype="PUI">615419891</itemid> <itemid idtype="CAR-ID">663398071</itemid> <itemid idtype="EMBASE">20170278829</itemid> <itemid idtype="NURSNG">2017134407</itemid> <itemid idtype="REAXYSCAR">20170689702</itemid> <itemid idtype="SCP">85017529486</itemid> <itemid idtype="SGR">85017529486</itemid> </itemidlist><history> <date-created day="02" month="05" timestamp="BST 16:18:28" year="2017"/> </history><dbcollection>EMBASE</dbcollection><dbcollection>NURSNG</dbcollection><dbcollection>REAXYSCAR</dbcollection><dbcollection>Scopusbase</dbcollection></item-info><head><citation-info><citation-type code="ar"/><citation-language xml:lang="eng" language="English"/><abstract-language xml:lang="eng" language="English"/><author-keywords> <author-keyword>BMI1</author-keyword> <author-keyword>MRNA expression</author-keyword> <author-keyword>Non-small cell lung cancer</author-keyword> <author-keyword>Peripheral whole blood</author-keyword> <author-keyword>Prognosis</author-keyword> </author-keywords></citation-info><citation-title><titletext original="y" xml:lang="eng" language="English">High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patients</titletext></citation-title><author-group><author auid="55241121900" seq="1" type="auth"><ce:initials>A.</ce:initials><ce:indexed-name>Koren A.</ce:indexed-name><ce:surname>Koren</ce:surname><ce:given-name>Ana</ce:given-name><preferred-name> <ce:initials>A.</ce:initials> <ce:indexed-name>Koren A.</ce:indexed-name> <ce:surname>Koren</ce:surname> <ce:given-name>Ana</ce:given-name> </preferred-name></author><author auid="36939704200" seq="2" type="auth"><ce:initials>M.</ce:initials><ce:indexed-name>Rijavec M.</ce:indexed-name><ce:surname>Rijavec</ce:surname><ce:given-name>Matija</ce:given-name><preferred-name> <ce:initials>M.</ce:initials> <ce:indexed-name>Rijavec M.</ce:indexed-name> <ce:surname>Rijavec</ce:surname> <ce:given-name>Matija</ce:given-name> </preferred-name></author><author auid="36992707400" seq="3" type="auth"><ce:initials>E.</ce:initials><ce:indexed-name>Sodja E.</ce:indexed-name><ce:surname>Sodja</ce:surname><ce:given-name>Eva</ce:given-name><preferred-name> <ce:initials>E.</ce:initials> <ce:indexed-name>Sodja E.</ce:indexed-name> <ce:surname>Sodja</ce:surname> <ce:given-name>Eva</ce:given-name> </preferred-name></author><author auid="7003295818" seq="4" type="auth"><ce:initials>I.</ce:initials><ce:indexed-name>Kern I.</ce:indexed-name><ce:surname>Kern</ce:surname><ce:given-name>Izidor</ce:given-name><preferred-name> <ce:initials>I.</ce:initials> <ce:indexed-name>Kern I.</ce:indexed-name> <ce:surname>Kern</ce:surname> <ce:given-name>Izidor</ce:given-name> </preferred-name></author><author auid="6701584602" date-locked="2017-07-01T00:16:07.860" seq="7" type="auth"><ce:initials>P.</ce:initials><ce:indexed-name>Korosec P.</ce:indexed-name><ce:surname>Korosec</ce:surname><ce:given-name>Peter</ce:given-name><preferred-name> <ce:initials>P.</ce:initials> <ce:indexed-name>Korosec P.</ce:indexed-name> <ce:surname>Korosec</ce:surname> <ce:given-name>Peter</ce:given-name> </preferred-name></author><author auid="7004393140" seq="8" type="auth"><ce:initials>T.</ce:initials><ce:indexed-name>Cufer T.</ce:indexed-name><ce:surname>Cufer</ce:surname><ce:given-name>Tanja</ce:given-name><preferred-name> <ce:initials>T.</ce:initials> <ce:indexed-name>Cufer T.</ce:indexed-name> <ce:surname>Cufer</ce:surname> <ce:given-name>Tanja</ce:given-name> </preferred-name></author><affiliation afid="60078312" country="svn"><organization>University Clinic Golnik</organization><city>Golnik</city><affiliation-id afid="60078312"/><country>Slovenia</country></affiliation></author-group><author-group><author auid="55883901600" seq="5" type="auth"><ce:initials>A.</ce:initials><ce:indexed-name>Sadikov A.</ce:indexed-name><ce:surname>Sadikov</ce:surname><ce:given-name>Aleksander</ce:given-name><preferred-name> <ce:initials>A.</ce:initials> <ce:indexed-name>Sadikov A.</ce:indexed-name> <ce:surname>Sadikov</ce:surname> <ce:given-name>Aleksander</ce:given-name> </preferred-name></author><affiliation afid="60031106" country="svn"><organization>University of Ljubljana</organization><organization>Faculty of Computer and Information Science</organization><city>Ljubljana</city><affiliation-id afid="60031106"/><country>Slovenia</country></affiliation></author-group><author-group><author auid="7005444734" seq="6" type="auth"><ce:initials>V.</ce:initials><ce:indexed-name>Kovac V.</ce:indexed-name><ce:surname>Kovac</ce:surname><ce:given-name>Viljem</ce:given-name><preferred-name> <ce:initials>V.</ce:initials> <ce:indexed-name>Kovac V.</ce:indexed-name> <ce:surname>Kovac</ce:surname> <ce:given-name>Viljem</ce:given-name> </preferred-name></author><affiliation afid="60000966" country="svn"><organization>Institute of Oncology Ljubljana</organization><city>Ljubljana</city><affiliation-id afid="60000966"/><country>Slovenia</country></affiliation></author-group><correspondence><person> <ce:initials>A.</ce:initials> <ce:indexed-name>Koren A.</ce:indexed-name> <ce:surname>Koren</ce:surname> <ce:given-name>Ana</ce:given-name> </person><affiliation country="svn"><organization>University Clinic Golnik</organization><city>Golnik</city><country>Slovenia</country></affiliation></correspondence><abstracts><abstract original="y" xml:lang="eng"> <ce:para>Polycomb group member protein BMI1 is involved in maintaining cell identity, proliferation, differentiation and human oncogenesis. In the present study, we determined BMI1 mRNA expression in whole blood and evaluated the impact of the expression level on the treatment response and survival of 96 advanced NSCLC patients treated with first-line platinum-based chemotherapy. We also determined BMI1 mRNA expression in primary tumors from 22 operable NSCLC patients treated with radical surgery. We found that compared with control subjects, BMI1 mRNA expression in whole blood of advanced NSCLC patients was decreased (P &lt; 0.001). Similarly, we observed decreased BMI1 mRNA expression in primary tumors compared to normal lungs from operable NSCLC patients (P=0.001). We found high BMI1 mRNA expression in blood was associated with longer progression-free survival (PFS) (P=0.049) and overall survival (OS) (P=0.012) in advanced NSCLC patients treated with first-line platinum-based chemotherapy. However, no association between the BMI1 mRNA level and response to chemotherapy was found (P=0.21). Multivariate Cox proportional hazards regression analysis showed elevated BMI1 mRNA level in whole blood was an independent prognostic factor for longer PFS (P=0.012) and OS (P &lt; 0.001). In conclusion, BMI1 mRNA expression in whole blood might represent a new biomarker for the diagnosis and prognosis of NSCLC.</ce:para> </abstract></abstracts><source country="usa" srcid="19900191708" type="j"><sourcetitle>Oncotarget</sourcetitle><sourcetitle-abbrev>Oncotarget</sourcetitle-abbrev><translated-sourcetitle xml:lang="eng">Oncotarget</translated-sourcetitle><issn type="electronic">19492553</issn><volisspag> <voliss issue="15" volume="8"/> <pagerange first="25384" last="25394"/> </volisspag><publicationyear first="2017"/><publicationdate> <year>2017</year> <date-text xfab-added="true">2017</date-text></publicationdate><website> <ce:e-address type="email">http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&amp;page=article&amp;op=download&amp;path%5B%5D=15914&amp;path%5B%5D=50877</ce:e-address> </website><publisher> <publishername>Impact Journals LLC</publishername> <ce:e-address type="email">editors@impactaging.com</ce:e-address> </publisher></source><enhancement><classificationgroup><classifications type="EMCLASS"> <classification> <classification-code>15</classification-code> <classification-description>Chest Diseases, Thoracic Surgery and Tuberculosis</classification-description> </classification> <classification> <classification-code>16</classification-code> <classification-description>Cancer</classification-description> </classification> <classification> <classification-code>22</classification-code> <classification-description>Human Genetics</classification-description> </classification> <classification> <classification-code>29</classification-code> <classification-description>Clinical and Experimental Biochemistry</classification-description> </classification> <classification> <classification-code>37</classification-code> <classification-description>Drug Literature Index</classification-description> </classification> </classifications><classifications type="ASJC"> <classification>2730</classification> </classifications><classifications type="SUBJABBR"><classification>MEDI</classification></classifications></classificationgroup><chemicalgroup> <chemicals source="esbd"> <chemical> <chemical-name>etoposide</chemical-name> <cas-registry-number>33419-42-0</cas-registry-number> </chemical> <chemical> <chemical-name>gemcitabine</chemical-name> <cas-registry-number>103882-84-4</cas-registry-number> </chemical> <chemical> <chemical-name>pemetrexed</chemical-name> <cas-registry-number>137281-23-3</cas-registry-number> <cas-registry-number>150399-23-8</cas-registry-number> </chemical> </chemicals> </chemicalgroup></enhancement></head><tail><bibliography refcount="49"> <reference id="1"> <ref-info> <ref-title> <ref-titletext>Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84918815964</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>J.</ce:initials> <ce:indexed-name>Ferlay J.</ce:indexed-name> <ce:surname>Ferlay</ce:surname> </author> <author seq="2"> <ce:initials>I.</ce:initials> <ce:indexed-name>Soerjomataram I.</ce:indexed-name> <ce:surname>Soerjomataram</ce:surname> </author> <author seq="3"> <ce:initials>R.</ce:initials> <ce:indexed-name>Dikshit R.</ce:indexed-name> <ce:surname>Dikshit</ce:surname> </author> <author seq="4"> <ce:initials>S.</ce:initials> <ce:indexed-name>Eser S.</ce:indexed-name> <ce:surname>Eser</ce:surname> </author> <author seq="5"> <ce:initials>C.</ce:initials> <ce:indexed-name>Mathers C.</ce:indexed-name> <ce:surname>Mathers</ce:surname> </author> <author seq="6"> <ce:initials>M.</ce:initials> <ce:indexed-name>Rebelo M.</ce:indexed-name> <ce:surname>Rebelo</ce:surname> </author> <author seq="7"> <ce:initials>D.M.</ce:initials> <ce:indexed-name>Parkin D.M.</ce:indexed-name> <ce:surname>Parkin</ce:surname> </author> <author seq="8"> <ce:initials>D.</ce:initials> <ce:indexed-name>Forman D.</ce:indexed-name> <ce:surname>Forman</ce:surname> </author> <author seq="9"> <ce:initials>F.</ce:initials> <ce:indexed-name>Bray F.</ce:indexed-name> <ce:surname>Bray</ce:surname> </author> </ref-authors> <ref-sourcetitle>Int J Cancer</ref-sourcetitle> <ref-publicationyear first="2015"/> <ref-volisspag> <voliss volume="136"/> <pagerange first="E359" last="E386"/> </ref-volisspag> </ref-info> <ref-fulltext>Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136: E359-86.</ref-fulltext> </reference> <reference id="2"> <ref-info> <refd-itemidlist> <itemid idtype="SGR">84892961071</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>J.</ce:initials> <ce:indexed-name>Ferlay J.</ce:indexed-name> <ce:surname>Ferlay</ce:surname> </author> <author seq="2"> <ce:initials>I.</ce:initials> <ce:indexed-name>Soerjomataram I.</ce:indexed-name> <ce:surname>Soerjomataram</ce:surname> </author> <author seq="3"> <ce:initials>M.</ce:initials> <ce:indexed-name>Ervik M.</ce:indexed-name> <ce:surname>Ervik</ce:surname> </author> <author seq="4"> <ce:initials>R.</ce:initials> <ce:indexed-name>Dikshit R.</ce:indexed-name> <ce:surname>Dikshit</ce:surname> </author> <author seq="5"> <ce:initials>S.</ce:initials> <ce:indexed-name>Eser S.</ce:indexed-name> <ce:surname>Eser</ce:surname> </author> <author seq="6"> <ce:initials>C.</ce:initials> <ce:indexed-name>Mathers C.</ce:indexed-name> <ce:surname>Mathers</ce:surname> </author> <author seq="7"> <ce:initials>M.</ce:initials> <ce:indexed-name>Rebelo M.</ce:indexed-name> <ce:surname>Rebelo</ce:surname> </author> <author seq="8"> <ce:initials>D.</ce:initials> <ce:indexed-name>Parkin D.</ce:indexed-name> <ce:surname>Parkin</ce:surname> </author> <author seq="9"> <ce:initials>D.</ce:initials> <ce:indexed-name>Forman D.</ce:indexed-name> <ce:surname>Forman</ce:surname> </author> <author seq="10"> <ce:initials>F.</ce:initials> <ce:indexed-name>Bray F.</ce:indexed-name> <ce:surname>Bray</ce:surname> </author> </ref-authors> <ref-sourcetitle>GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide</ref-sourcetitle> <ref-publicationyear first="2013"/> <ref-website> <ce:e-address type="email">http://globocan.iarc.fr</ce:e-address> </ref-website> <ref-text>IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer, accessed on 16/07/2016</ref-text> </ref-info> <ref-fulltext>Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2013. Available from: http://globocan.iarc.fr, accessed on 16/07/2016.</ref-fulltext> </reference> <reference id="3"> <ref-info> <ref-title> <ref-titletext>Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84891371558</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>R.</ce:initials> <ce:indexed-name>De Angelis R.</ce:indexed-name> <ce:surname>De Angelis</ce:surname> </author> <author seq="2"> <ce:initials>M.</ce:initials> <ce:indexed-name>Sant M.</ce:indexed-name> <ce:surname>Sant</ce:surname> </author> <author seq="3"> <ce:initials>M.P.</ce:initials> <ce:indexed-name>Coleman M.P.</ce:indexed-name> <ce:surname>Coleman</ce:surname> </author> <author seq="4"> <ce:initials>S.</ce:initials> <ce:indexed-name>Francisci S.</ce:indexed-name> <ce:surname>Francisci</ce:surname> </author> <author seq="5"> <ce:initials>P.</ce:initials> <ce:indexed-name>Baili P.</ce:indexed-name> <ce:surname>Baili</ce:surname> </author> <author seq="6"> <ce:initials>D.</ce:initials> <ce:indexed-name>Pierannunzio D.</ce:indexed-name> <ce:surname>Pierannunzio</ce:surname> </author> <author seq="7"> <ce:initials>A.</ce:initials> <ce:indexed-name>Trama A.</ce:indexed-name> <ce:surname>Trama</ce:surname> </author> <author seq="8"> <ce:initials>O.</ce:initials> <ce:indexed-name>Visser O.</ce:indexed-name> <ce:surname>Visser</ce:surname> </author> <author seq="9"> <ce:initials>H.</ce:initials> <ce:indexed-name>Brenner H.</ce:indexed-name> <ce:surname>Brenner</ce:surname> </author> <author seq="10"> <ce:initials>E.</ce:initials> <ce:indexed-name>Ardanaz E.</ce:indexed-name> <ce:surname>Ardanaz</ce:surname> </author> <author seq="11"> <ce:initials>M.</ce:initials> <ce:indexed-name>Bielska-Lasota M.</ce:indexed-name> <ce:surname>Bielska-Lasota</ce:surname> </author> <author seq="12"> <ce:initials>G.</ce:initials> <ce:indexed-name>Engholm G.</ce:indexed-name> <ce:surname>Engholm</ce:surname> </author> <author seq="13"> <ce:initials>A.</ce:initials> <ce:indexed-name>Nennecke A.</ce:indexed-name> <ce:surname>Nennecke</ce:surname> </author> <et-al/> </ref-authors> <ref-sourcetitle>Lancet Oncol</ref-sourcetitle> <ref-publicationyear first="2013"/> <ref-volisspag> <voliss volume="2045"/> <pagerange first="1" last="12"/> </ref-volisspag> </ref-info> <ref-fulltext>De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol. 2013; 2045: 1-12.</ref-fulltext> </reference> <reference id="4"> <ref-info> <ref-title> <ref-titletext>Lung cancer: diagnosis and management</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">33846102093</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>L.G.</ce:initials> <ce:indexed-name>Collins L.G.</ce:indexed-name> <ce:surname>Collins</ce:surname> </author> <author seq="2"> <ce:initials>C.</ce:initials> <ce:indexed-name>Haines C.</ce:indexed-name> <ce:surname>Haines</ce:surname> </author> <author seq="3"> <ce:initials>R.</ce:initials> <ce:indexed-name>Perkel R.</ce:indexed-name> <ce:surname>Perkel</ce:surname> </author> <author seq="4"> <ce:initials>R.E.</ce:initials> <ce:indexed-name>Enck R.E.</ce:indexed-name> <ce:surname>Enck</ce:surname> </author> </ref-authors> <ref-sourcetitle>Am Fam Physician</ref-sourcetitle> <ref-publicationyear first="2007"/> <ref-volisspag> <voliss volume="75"/> <pagerange first="56" last="63"/> </ref-volisspag> </ref-info> <ref-fulltext>Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. Am Fam Physician. 2007; 75: 56-63.</ref-fulltext> </reference> <reference id="5"> <ref-info> <ref-title> <ref-titletext>Genotyping and genomic profiling of non-small-cell lung cancer: Implications for current and future therapies</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84875937242</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>T.</ce:initials> <ce:indexed-name>Li T.</ce:indexed-name> <ce:surname>Li</ce:surname> </author> <author seq="2"> <ce:initials>H.J.</ce:initials> <ce:indexed-name>Kung H.J.</ce:indexed-name> <ce:surname>Kung</ce:surname> </author> <author seq="3"> <ce:initials>P.C.</ce:initials> <ce:indexed-name>Mack P.C.</ce:indexed-name> <ce:surname>Mack</ce:surname> </author> <author seq="4"> <ce:initials>D.R.</ce:initials> <ce:indexed-name>Gandara D.R.</ce:indexed-name> <ce:surname>Gandara</ce:surname> </author> </ref-authors> <ref-sourcetitle>J Clin Oncol</ref-sourcetitle> <ref-publicationyear first="2013"/> <ref-volisspag> <voliss volume="31"/> <pagerange first="1039" last="1049"/> </ref-volisspag> </ref-info> <ref-fulltext>Li T, Kung HJ, Mack PC, Gandara DR. Genotyping and genomic profiling of non-small-cell lung cancer: Implications for current and future therapies. J Clin Oncol. 2013; 31: 1039-49.</ref-fulltext> </reference> <reference id="6"> <ref-info> <ref-title> <ref-titletext>Update on systemic therapy of advanced non-small-cell lung cancer</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84907553976</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>T.</ce:initials> <ce:indexed-name>Cufer T.</ce:indexed-name> <ce:surname>Cufer</ce:surname> </author> <author seq="2"> <ce:initials>L.</ce:initials> <ce:indexed-name>Knez L.</ce:indexed-name> <ce:surname>Knez</ce:surname> </author> </ref-authors> <ref-sourcetitle>Expert Rev Anticancer Ther</ref-sourcetitle> <ref-publicationyear first="2014"/> <ref-volisspag> <voliss volume="14"/> <pagerange first="1189" last="1203"/> </ref-volisspag> </ref-info> <ref-fulltext>Cufer T, Knez L. Update on systemic therapy of advanced non-small-cell lung cancer. Expert Rev Anticancer Ther. 2014; 14: 1189-203.</ref-fulltext> </reference> <reference id="7"> <ref-info> <ref-title> <ref-titletext>Circulating tumor-derived biomarkers in lung cancer</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84868271933</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>A.</ce:initials> <ce:indexed-name>Taenzer A.</ce:indexed-name> <ce:surname>Taenzer</ce:surname> </author> <author seq="2"> <ce:initials>C.</ce:initials> <ce:indexed-name>Alix-Panabieres C.</ce:indexed-name> <ce:surname>Alix-Panabières</ce:surname> </author> <author seq="3"> <ce:initials>H.</ce:initials> <ce:indexed-name>Wikman H.</ce:indexed-name> <ce:surname>Wikman</ce:surname> </author> <author seq="4"> <ce:initials>K.</ce:initials> <ce:indexed-name>Pantel K.</ce:indexed-name> <ce:surname>Pantel</ce:surname> </author> </ref-authors> <ref-sourcetitle>J Thorac Dis</ref-sourcetitle> <ref-publicationyear first="2012"/> <ref-volisspag> <voliss volume="4"/> <pagerange first="448" last="449"/> </ref-volisspag> </ref-info> <ref-fulltext>Taenzer A, Alix-Panabières C, Wikman H, Pantel K. Circulating tumor-derived biomarkers in lung cancer. J Thorac Dis. 2012; 4: 448-9.</ref-fulltext> </reference> <reference id="8"> <ref-info> <ref-title> <ref-titletext>Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">81855208762</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>K.</ce:initials> <ce:indexed-name>Taniguchi K.</ce:indexed-name> <ce:surname>Taniguchi</ce:surname> </author> <author seq="2"> <ce:initials>J.</ce:initials> <ce:indexed-name>Uchida J.</ce:indexed-name> <ce:surname>Uchida</ce:surname> </author> <author seq="3"> <ce:initials>K.</ce:initials> <ce:indexed-name>Nishino K.</ce:indexed-name> <ce:surname>Nishino</ce:surname> </author> <author seq="4"> <ce:initials>T.</ce:initials> <ce:indexed-name>Kumagai T.</ce:indexed-name> <ce:surname>Kumagai</ce:surname> </author> <author seq="5"> <ce:initials>T.</ce:initials> <ce:indexed-name>Okuyama T.</ce:indexed-name> <ce:surname>Okuyama</ce:surname> </author> <author seq="6"> <ce:initials>J.</ce:initials> <ce:indexed-name>Okami J.</ce:indexed-name> <ce:surname>Okami</ce:surname> </author> <author seq="7"> <ce:initials>M.</ce:initials> <ce:indexed-name>Higashiyama M.</ce:indexed-name> <ce:surname>Higashiyama</ce:surname> </author> <author seq="8"> <ce:initials>K.</ce:initials> <ce:indexed-name>Kodama K.</ce:indexed-name> <ce:surname>Kodama</ce:surname> </author> <author seq="9"> <ce:initials>F.</ce:initials> <ce:indexed-name>Imamura F.</ce:indexed-name> <ce:surname>Imamura</ce:surname> </author> <author seq="10"> <ce:initials>K.</ce:initials> <ce:indexed-name>Kato K.</ce:indexed-name> <ce:surname>Kato</ce:surname> </author> </ref-authors> <ref-sourcetitle>Clin Cancer Res</ref-sourcetitle> <ref-publicationyear first="2011"/> <ref-volisspag> <voliss volume="17"/> <pagerange first="7808" last="7815"/> </ref-volisspag> </ref-info> <ref-fulltext>Taniguchi K, Uchida J, Nishino K, Kumagai T, Okuyama T, Okami J, Higashiyama M, Kodama K, Imamura F, Kato K. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas. Clin Cancer Res. 2011; 17: 7808-15.</ref-fulltext> </reference> <reference id="9"> <ref-info> <ref-title> <ref-titletext>Bloodbased gene expression signatures in non-small cell lung cancer</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">79956016694</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>T.</ce:initials> <ce:indexed-name>Zander T.</ce:indexed-name> <ce:surname>Zander</ce:surname> </author> <author seq="2"> <ce:initials>A.</ce:initials> <ce:indexed-name>Hofmann A.</ce:indexed-name> <ce:surname>Hofmann</ce:surname> </author> <author seq="3"> <ce:initials>A.</ce:initials> <ce:indexed-name>Staratschek-Jox A.</ce:indexed-name> <ce:surname>Staratschek-Jox</ce:surname> </author> <author seq="4"> <ce:initials>S.</ce:initials> <ce:indexed-name>Classen S.</ce:indexed-name> <ce:surname>Classen</ce:surname> </author> <author seq="5"> <ce:initials>S.</ce:initials> <ce:indexed-name>Debey-Pascher S.</ce:indexed-name> <ce:surname>Debey-Pascher</ce:surname> </author> <author seq="6"> <ce:initials>D.</ce:initials> <ce:indexed-name>Maisel D.</ce:indexed-name> <ce:surname>Maisel</ce:surname> </author> <author seq="7"> <ce:initials>S.</ce:initials> <ce:indexed-name>Ansen S.</ce:indexed-name> <ce:surname>Ansén</ce:surname> </author> <author seq="8"> <ce:initials>M.</ce:initials> <ce:indexed-name>Hahn M.</ce:indexed-name> <ce:surname>Hahn</ce:surname> </author> <author seq="9"> <ce:initials>M.</ce:initials> <ce:indexed-name>Beyer M.</ce:indexed-name> <ce:surname>Beyer</ce:surname> </author> <author seq="10"> <ce:initials>R.K.</ce:initials> <ce:indexed-name>Thomas R.K.</ce:indexed-name> <ce:surname>Thomas</ce:surname> </author> <author seq="11"> <ce:initials>B.</ce:initials> <ce:indexed-name>Gathof B.</ce:indexed-name> <ce:surname>Gathof</ce:surname> </author> <author seq="12"> <ce:initials>C.</ce:initials> <ce:indexed-name>Mauch C.</ce:indexed-name> <ce:surname>Mauch</ce:surname> </author> <author seq="13"> <ce:initials>K.S.</ce:initials> <ce:indexed-name>Delank K.S.</ce:indexed-name> <ce:surname>Delank</ce:surname> </author> <et-al/> </ref-authors> <ref-sourcetitle>Clin Cancer Res</ref-sourcetitle> <ref-publicationyear first="2011"/> <ref-volisspag> <voliss volume="17"/> <pagerange first="3360" last="3367"/> </ref-volisspag> </ref-info> <ref-fulltext>Zander T, Hofmann A, Staratschek-Jox A, Classen S, Debey-Pascher S, Maisel D, Ansén S, Hahn M, Beyer M, Thomas RK, Gathof B, Mauch C, Delank KS, et al. Bloodbased gene expression signatures in non-small cell lung cancer. Clin Cancer Res. 2011; 17: 3360-7.</ref-fulltext> </reference> <reference id="10"> <ref-info> <ref-title> <ref-titletext>SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">58849115512</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>A.C.</ce:initials> <ce:indexed-name>Moss A.C.</ce:indexed-name> <ce:surname>Moss</ce:surname> </author> <author seq="2"> <ce:initials>G.M.</ce:initials> <ce:indexed-name>Jacobson G.M.</ce:indexed-name> <ce:surname>Jacobson</ce:surname> </author> <author seq="3"> <ce:initials>L.E.</ce:initials> <ce:indexed-name>Walker L.E.</ce:indexed-name> <ce:surname>Walker</ce:surname> </author> <author seq="4"> <ce:initials>N.W.</ce:initials> <ce:indexed-name>Blake N.W.</ce:indexed-name> <ce:surname>Blake</ce:surname> </author> <author seq="5"> <ce:initials>E.</ce:initials> <ce:indexed-name>Marshall E.</ce:indexed-name> <ce:surname>Marshall</ce:surname> </author> <author seq="6"> <ce:initials>J.M.</ce:initials> <ce:indexed-name>Coulson J.M.</ce:indexed-name> <ce:surname>Coulson</ce:surname> </author> </ref-authors> <ref-sourcetitle>Clin Cancer Res</ref-sourcetitle> <ref-publicationyear first="2009"/> <ref-volisspag> <voliss volume="15"/> <pagerange first="274" last="283"/> </ref-volisspag> </ref-info> <ref-fulltext>Moss AC, Jacobson GM, Walker LE, Blake NW, Marshall E, Coulson JM. SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer. Clin Cancer Res. 2009; 15: 274-83.</ref-fulltext> </reference> <reference id="11"> <ref-info> <ref-title> <ref-titletext>A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">80053929852</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>M.</ce:initials> <ce:indexed-name>Rotunno M.</ce:indexed-name> <ce:surname>Rotunno</ce:surname> </author> <author seq="2"> <ce:initials>N.</ce:initials> <ce:indexed-name>Hu N.</ce:indexed-name> <ce:surname>Hu</ce:surname> </author> <author seq="3"> <ce:initials>H.</ce:initials> <ce:indexed-name>Su H.</ce:indexed-name> <ce:surname>Su</ce:surname> </author> <author seq="4"> <ce:initials>C.</ce:initials> <ce:indexed-name>Wang C.</ce:indexed-name> <ce:surname>Wang</ce:surname> </author> <author seq="5"> <ce:initials>A.M.</ce:initials> <ce:indexed-name>Goldstein A.M.</ce:indexed-name> <ce:surname>Goldstein</ce:surname> </author> <author seq="6"> <ce:initials>A.W.</ce:initials> <ce:indexed-name>Bergen A.W.</ce:indexed-name> <ce:surname>Bergen</ce:surname> </author> <author seq="7"> <ce:initials>D.</ce:initials> <ce:indexed-name>Consonni D.</ce:indexed-name> <ce:surname>Consonni</ce:surname> </author> <author seq="8"> <ce:initials>A.C.</ce:initials> <ce:indexed-name>Pesatori A.C.</ce:indexed-name> <ce:surname>Pesatori</ce:surname> </author> <author seq="9"> <ce:initials>P.A.</ce:initials> <ce:indexed-name>Bertazzi P.A.</ce:indexed-name> <ce:surname>Bertazzi</ce:surname> </author> <author seq="10"> <ce:initials>S.</ce:initials> <ce:indexed-name>Wacholder S.</ce:indexed-name> <ce:surname>Wacholder</ce:surname> </author> <author seq="11"> <ce:initials>J.</ce:initials> <ce:indexed-name>Shih J.</ce:indexed-name> <ce:surname>Shih</ce:surname> </author> <author seq="12"> <ce:initials>N.E.</ce:initials> <ce:indexed-name>Caporaso N.E.</ce:indexed-name> <ce:surname>Caporaso</ce:surname> </author> <author seq="13"> <ce:initials>P.R.</ce:initials> <ce:indexed-name>Taylor P.R.</ce:indexed-name> <ce:surname>Taylor</ce:surname> </author> <et-al/> </ref-authors> <ref-sourcetitle>Cancer Prev Res</ref-sourcetitle> <ref-publicationyear first="2011"/> <ref-volisspag> <voliss volume="4"/> <pagerange first="1599" last="1608"/> </ref-volisspag> </ref-info> <ref-fulltext>Rotunno M, Hu N, Su H, Wang C, Goldstein AM, Bergen AW, Consonni D, Pesatori AC, Bertazzi PA, Wacholder S, Shih J, Caporaso NE, Taylor PR, et al. A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma. Cancer Prev Res. 2011; 4: 1599-608.</ref-fulltext> </reference> <reference id="12"> <ref-info> <ref-title> <ref-titletext>The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84968783394</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>E.</ce:initials> <ce:indexed-name>Sodja E.</ce:indexed-name> <ce:surname>Sodja</ce:surname> </author> <author seq="2"> <ce:initials>M.</ce:initials> <ce:indexed-name>Rijavec M.</ce:indexed-name> <ce:surname>Rijavec</ce:surname> </author> <author seq="3"> <ce:initials>A.</ce:initials> <ce:indexed-name>Koren A.</ce:indexed-name> <ce:surname>Koren</ce:surname> </author> <author seq="4"> <ce:initials>A.</ce:initials> <ce:indexed-name>Sadikov A.</ce:indexed-name> <ce:surname>Sadikov</ce:surname> </author> <author seq="5"> <ce:initials>P.</ce:initials> <ce:indexed-name>Korosec P.</ce:indexed-name> <ce:surname>Korošec</ce:surname> </author> <author seq="6"> <ce:initials>T.</ce:initials> <ce:indexed-name>Cufer T.</ce:indexed-name> <ce:surname>Cufer</ce:surname> </author> </ref-authors> <ref-sourcetitle>Radiol Oncol</ref-sourcetitle> <ref-publicationyear first="2016"/> <ref-volisspag> <voliss volume="50"/> <pagerange first="188" last="196"/> </ref-volisspag> </ref-info> <ref-fulltext>Sodja E, Rijavec M, Koren A, Sadikov A, Korošec P, Cufer T. The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer. Radiol Oncol. 2016; 50: 188-96.</ref-fulltext> </reference> <reference id="13"> <ref-info> <ref-title> <ref-titletext>Stability of endogenous and added RNA in blood specimens, serum, and plasma</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">0036794062</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>N.B.Y.</ce:initials> <ce:indexed-name>Tsui N.B.Y.</ce:indexed-name> <ce:surname>Tsui</ce:surname> </author> <author seq="2"> <ce:initials>E.K.O.</ce:initials> <ce:indexed-name>Ng E.K.O.</ce:indexed-name> <ce:surname>Ng</ce:surname> </author> <author seq="3"> <ce:initials>Y.M.D.</ce:initials> <ce:indexed-name>Lo Y.M.D.</ce:indexed-name> <ce:surname>Lo</ce:surname> </author> </ref-authors> <ref-sourcetitle>Clin Chem</ref-sourcetitle> <ref-publicationyear first="2002"/> <ref-volisspag> <voliss volume="48"/> <pagerange first="1647" last="1653"/> </ref-volisspag> </ref-info> <ref-fulltext>Tsui NBY, Ng EKO, Lo YMD. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem. 2002; 48: 1647-53.</ref-fulltext> </reference> <reference id="14"> <ref-info> <ref-title> <ref-titletext>Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="ARTNUM">R60</itemid> <itemid idtype="SGR">79958181044</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>E.</ce:initials> <ce:indexed-name>Saloustros E.</ce:indexed-name> <ce:surname>Saloustros</ce:surname> </author> <author seq="2"> <ce:initials>M.</ce:initials> <ce:indexed-name>Perraki M.</ce:indexed-name> <ce:surname>Perraki</ce:surname> </author> <author seq="3"> <ce:initials>S.</ce:initials> <ce:indexed-name>Apostolaki S.</ce:indexed-name> <ce:surname>Apostolaki</ce:surname> </author> <author seq="4"> <ce:initials>G.</ce:initials> <ce:indexed-name>Kallergi G.</ce:indexed-name> <ce:surname>Kallergi</ce:surname> </author> <author seq="5"> <ce:initials>A.</ce:initials> <ce:indexed-name>Xyrafas A.</ce:indexed-name> <ce:surname>Xyrafas</ce:surname> </author> <author seq="6"> <ce:initials>K.</ce:initials> <ce:indexed-name>Kalbakis K.</ce:indexed-name> <ce:surname>Kalbakis</ce:surname> </author> <author seq="7"> <ce:initials>S.</ce:initials> <ce:indexed-name>Agelaki S.</ce:indexed-name> <ce:surname>Agelaki</ce:surname> </author> <author seq="8"> <ce:initials>A.</ce:initials> <ce:indexed-name>Kalykaki A.</ce:indexed-name> <ce:surname>Kalykaki</ce:surname> </author> <author seq="9"> <ce:initials>V.</ce:initials> <ce:indexed-name>Georgoulias V.</ce:indexed-name> <ce:surname>Georgoulias</ce:surname> </author> <author seq="10"> <ce:initials>D.</ce:initials> <ce:indexed-name>Mavroudis D.</ce:indexed-name> <ce:surname>Mavroudis</ce:surname> </author> </ref-authors> <ref-sourcetitle>Breast Cancer Res</ref-sourcetitle> <ref-publicationyear first="2011"/> <ref-volisspag> <voliss volume="13"/> </ref-volisspag> </ref-info> <ref-fulltext>Saloustros E, Perraki M, Apostolaki S, Kallergi G, Xyrafas A, Kalbakis K, Agelaki S, Kalykaki A, Georgoulias V, Mavroudis D. Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse. Breast Cancer Res. 2011; 13: R60.</ref-fulltext> </reference> <reference id="15"> <ref-info> <ref-title> <ref-titletext>Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">61649109505</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>K.</ce:initials> <ce:indexed-name>Vartanian K.</ce:indexed-name> <ce:surname>Vartanian</ce:surname> </author> <author seq="2"> <ce:initials>R.</ce:initials> <ce:indexed-name>Slottke R.</ce:indexed-name> <ce:surname>Slottke</ce:surname> </author> <author seq="3"> <ce:initials>T.</ce:initials> <ce:indexed-name>Johnstone T.</ce:indexed-name> <ce:surname>Johnstone</ce:surname> </author> <author seq="4"> <ce:initials>A.</ce:initials> <ce:indexed-name>Casale A.</ce:indexed-name> <ce:surname>Casale</ce:surname> </author> <author seq="5"> <ce:initials>S.R.</ce:initials> <ce:indexed-name>Planck S.R.</ce:indexed-name> <ce:surname>Planck</ce:surname> </author> <author seq="6"> <ce:initials>D.</ce:initials> <ce:indexed-name>Choi D.</ce:indexed-name> <ce:surname>Choi</ce:surname> </author> <author seq="7"> <ce:initials>J.R.</ce:initials> <ce:indexed-name>Smith J.R.</ce:indexed-name> <ce:surname>Smith</ce:surname> </author> <author seq="8"> <ce:initials>J.T.</ce:initials> <ce:indexed-name>Rosenbaum J.T.</ce:indexed-name> <ce:surname>Rosenbaum</ce:surname> </author> <author seq="9"> <ce:initials>C.A.</ce:initials> <ce:indexed-name>Harrington C.A.</ce:indexed-name> <ce:surname>Harrington</ce:surname> </author> </ref-authors> <ref-sourcetitle>BMC Genomics</ref-sourcetitle> <ref-publicationyear first="2009"/> <ref-volisspag> <voliss volume="10"/> <pagerange first="2"/> </ref-volisspag> </ref-info> <ref-fulltext>Vartanian K, Slottke R, Johnstone T, Casale A, Planck SR, Choi D, Smith JR, Rosenbaum JT, Harrington CA. Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis. BMC Genomics. 2009; 10: 2.</ref-fulltext> </reference> <reference id="16"> <ref-info> <ref-title> <ref-titletext>RNA-Seq: a revolutionary tool for transcriptomics</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">57749195712</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>Z.</ce:initials> <ce:indexed-name>Wang Z.</ce:indexed-name> <ce:surname>Wang</ce:surname> </author> <author seq="2"> <ce:initials>M.</ce:initials> <ce:indexed-name>Gerstein M.</ce:indexed-name> <ce:surname>Gerstein</ce:surname> </author> <author seq="3"> <ce:initials>M.</ce:initials> <ce:indexed-name>Snyder M.</ce:indexed-name> <ce:surname>Snyder</ce:surname> </author> </ref-authors> <ref-sourcetitle>Nat Rev Genet</ref-sourcetitle> <ref-publicationyear first="2009"/> <ref-volisspag> <voliss volume="10"/> <pagerange first="57" last="63"/> </ref-volisspag> </ref-info> <ref-fulltext>Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009; 10: 57-63.</ref-fulltext> </reference> <reference id="17"> <ref-info> <ref-title> <ref-titletext>Comparison of whole blood RNA preservation tubes and novel generation RNA extraction kits for analysis of mRNA and miRNA profiles</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84915733870</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>M.</ce:initials> <ce:indexed-name>Hantzsch M.</ce:indexed-name> <ce:surname>Hantzsch</ce:surname> </author> <author seq="2"> <ce:initials>A.</ce:initials> <ce:indexed-name>Tolios A.</ce:indexed-name> <ce:surname>Tolios</ce:surname> </author> <author seq="3"> <ce:initials>F.</ce:initials> <ce:indexed-name>Beutner F.</ce:indexed-name> <ce:surname>Beutner</ce:surname> </author> <author seq="4"> <ce:initials>D.</ce:initials> <ce:indexed-name>Nagel D.</ce:indexed-name> <ce:surname>Nagel</ce:surname> </author> <author seq="5"> <ce:initials>J.</ce:initials> <ce:indexed-name>Thiery J.</ce:indexed-name> <ce:surname>Thiery</ce:surname> </author> <author seq="6"> <ce:initials>D.</ce:initials> <ce:indexed-name>Teupser D.</ce:indexed-name> <ce:surname>Teupser</ce:surname> </author> <author seq="7"> <ce:initials>L.M.</ce:initials> <ce:indexed-name>Holdt L.M.</ce:indexed-name> <ce:surname>Holdt</ce:surname> </author> </ref-authors> <ref-sourcetitle>PLoS One</ref-sourcetitle> <ref-publicationyear first="2014"/> <ref-volisspag> <voliss volume="9"/> <pagerange first="1" last="17"/> </ref-volisspag> </ref-info> <ref-fulltext>Hantzsch M, Tolios A, Beutner F, Nagel D, Thiery J, Teupser D, Holdt LM. Comparison of whole blood RNA preservation tubes and novel generation RNA extraction kits for analysis of mRNA and miRNA profiles. PLoS One. 2014; 9: 1-17.</ref-fulltext> </reference> <reference id="18"> <ref-info> <ref-title> <ref-titletext>Division of labor in Polycomb group repression</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">4344666089</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>S.S.</ce:initials> <ce:indexed-name>Levine S.S.</ce:indexed-name> <ce:surname>Levine</ce:surname> </author> <author seq="2"> <ce:initials>I.F.G.</ce:initials> <ce:indexed-name>King I.F.G.</ce:indexed-name> <ce:surname>King</ce:surname> </author> <author seq="3"> <ce:initials>R.E.</ce:initials> <ce:indexed-name>Kingston R.E.</ce:indexed-name> <ce:surname>Kingston</ce:surname> </author> </ref-authors> <ref-sourcetitle>Trends Biochem Sci</ref-sourcetitle> <ref-publicationyear first="2004"/> <ref-volisspag> <voliss volume="29"/> <pagerange first="478" last="485"/> </ref-volisspag> </ref-info> <ref-fulltext>Levine SS, King IFG, Kingston RE. Division of labor in Polycomb group repression. Trends Biochem Sci. 2004; 29: 478-85.</ref-fulltext> </reference> <reference id="19"> <ref-info> <ref-title> <ref-titletext>Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">0035877978</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>F.J.</ce:initials> <ce:indexed-name>van Kemenade F.J.</ce:indexed-name> <ce:surname>van Kemenade</ce:surname> </author> <author seq="2"> <ce:initials>F.M.</ce:initials> <ce:indexed-name>Raaphorst F.M.</ce:indexed-name> <ce:surname>Raaphorst</ce:surname> </author> <author seq="3"> <ce:initials>T.</ce:initials> <ce:indexed-name>Blokzijl T.</ce:indexed-name> <ce:surname>Blokzijl</ce:surname> </author> <author seq="4"> <ce:initials>E.</ce:initials> <ce:indexed-name>Fieret E.</ce:indexed-name> <ce:surname>Fieret</ce:surname> </author> <author seq="5"> <ce:initials>K.M.</ce:initials> <ce:indexed-name>Hamer K.M.</ce:indexed-name> <ce:surname>Hamer</ce:surname> </author> <author seq="6"> <ce:initials>D.P.</ce:initials> <ce:indexed-name>Satijn D.P.</ce:indexed-name> <ce:surname>Satijn</ce:surname> </author> <author seq="7"> <ce:initials>A.P.</ce:initials> <ce:indexed-name>Otte A.P.</ce:indexed-name> <ce:surname>Otte</ce:surname> </author> <author seq="8"> <ce:initials>C.J.</ce:initials> <ce:indexed-name>Meijer C.J.</ce:indexed-name> <ce:surname>Meijer</ce:surname> </author> </ref-authors> <ref-sourcetitle>Blood</ref-sourcetitle> <ref-publicationyear first="2001"/> <ref-volisspag> <voliss volume="97"/> <pagerange first="3896" last="3901"/> </ref-volisspag> </ref-info> <ref-fulltext>van Kemenade FJ, Raaphorst FM, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP, Meijer CJ. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood. 2001; 97: 3896-901.</ref-fulltext> </reference> <reference id="20"> <ref-info> <ref-title> <ref-titletext>BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">0035866814</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>S.</ce:initials> <ce:indexed-name>Bea S.</ce:indexed-name> <ce:surname>Beà</ce:surname> </author> <author seq="2"> <ce:initials>F.</ce:initials> <ce:indexed-name>Tort F.</ce:indexed-name> <ce:surname>Tort</ce:surname> </author> <author seq="3"> <ce:initials>M.</ce:initials> <ce:indexed-name>Pinyol M.</ce:indexed-name> <ce:surname>Pinyol</ce:surname> </author> <author seq="4"> <ce:initials>X.</ce:initials> <ce:indexed-name>Puig X.</ce:indexed-name> <ce:surname>Puig</ce:surname> </author> <author seq="5"> <ce:initials>L.</ce:initials> <ce:indexed-name>Hernandez L.</ce:indexed-name> <ce:surname>Hernández</ce:surname> </author> <author seq="6"> <ce:initials>S.</ce:initials> <ce:indexed-name>Hernandez S.</ce:indexed-name> <ce:surname>Hernández</ce:surname> </author> <author seq="7"> <ce:initials>P.L.</ce:initials> <ce:indexed-name>Fernandez P.L.</ce:indexed-name> <ce:surname>Fernandez</ce:surname> </author> <author seq="8"> <ce:initials>M.</ce:initials> <ce:indexed-name>van Lohuizen M.</ce:indexed-name> <ce:surname>van Lohuizen</ce:surname> </author> <author seq="9"> <ce:initials>D.</ce:initials> <ce:indexed-name>Colomer D.</ce:indexed-name> <ce:surname>Colomer</ce:surname> </author> <author seq="10"> <ce:initials>E.</ce:initials> <ce:indexed-name>Campo E.</ce:indexed-name> <ce:surname>Campo</ce:surname> </author> </ref-authors> <ref-sourcetitle>Cancer Res</ref-sourcetitle> <ref-publicationyear first="2001"/> <ref-volisspag> <voliss volume="61"/> <pagerange first="2409" last="2412"/> </ref-volisspag> </ref-info> <ref-fulltext>Beà S, Tort F, Pinyol M, Puig X, Hernández L, Hernández S, Fernandez PL, van Lohuizen M, Colomer D, Campo E. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 2001; 61: 2409-12.</ref-fulltext> </reference> <reference id="21"> <ref-info> <ref-title> <ref-titletext>Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">0034492916</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>F.M.</ce:initials> <ce:indexed-name>Raaphorst F.M.</ce:indexed-name> <ce:surname>Raaphorst</ce:surname> </author> <author seq="2"> <ce:initials>F.J.</ce:initials> <ce:indexed-name>van Kemenade F.J.</ce:indexed-name> <ce:surname>van Kemenade</ce:surname> </author> <author seq="3"> <ce:initials>T.</ce:initials> <ce:indexed-name>Blokzijl T.</ce:indexed-name> <ce:surname>Blokzijl</ce:surname> </author> <author seq="4"> <ce:initials>E.</ce:initials> <ce:indexed-name>Fieret E.</ce:indexed-name> <ce:surname>Fieret</ce:surname> </author> <author seq="5"> <ce:initials>K.M.</ce:initials> <ce:indexed-name>Hamer K.M.</ce:indexed-name> <ce:surname>Hamer</ce:surname> </author> <author seq="6"> <ce:initials>D.P.</ce:initials> <ce:indexed-name>Satijn D.P.</ce:indexed-name> <ce:surname>Satijn</ce:surname> </author> <author seq="7"> <ce:initials>A.P.</ce:initials> <ce:indexed-name>Otte A.P.</ce:indexed-name> <ce:surname>Otte</ce:surname> </author> <author seq="8"> <ce:initials>C.J.</ce:initials> <ce:indexed-name>Meijer C.J.</ce:indexed-name> <ce:surname>Meijer</ce:surname> </author> </ref-authors> <ref-sourcetitle>Am J Pathol</ref-sourcetitle> <ref-publicationyear first="2000"/> <ref-volisspag> <voliss volume="157"/> <pagerange first="709" last="715"/> </ref-volisspag> </ref-info> <ref-fulltext>Raaphorst FM, van Kemenade FJ, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP, Meijer CJ. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol. 2000; 157: 709-15.</ref-fulltext> </reference> <reference id="22"> <ref-info> <ref-title> <ref-titletext>Bmi-1 expression predicts prognosis for patients with gastric carcinoma</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">39749120638</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>J.H.</ce:initials> <ce:indexed-name>Liu J.H.</ce:indexed-name> <ce:surname>Liu</ce:surname> </author> <author seq="2"> <ce:initials>L.B.</ce:initials> <ce:indexed-name>Song L.B.</ce:indexed-name> <ce:surname>Song</ce:surname> </author> <author seq="3"> <ce:initials>X.</ce:initials> <ce:indexed-name>Zhang X.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="4"> <ce:initials>B.H.</ce:initials> <ce:indexed-name>Guo B.H.</ce:indexed-name> <ce:surname>Guo</ce:surname> </author> <author seq="5"> <ce:initials>Y.</ce:initials> <ce:indexed-name>Feng Y.</ce:indexed-name> <ce:surname>Feng</ce:surname> </author> <author seq="6"> <ce:initials>X.X.</ce:initials> <ce:indexed-name>Li X.X.</ce:indexed-name> <ce:surname>Li</ce:surname> </author> <author seq="7"> <ce:initials>W.T.</ce:initials> <ce:indexed-name>Liao W.T.</ce:indexed-name> <ce:surname>Liao</ce:surname> </author> <author seq="8"> <ce:initials>M.S.</ce:initials> <ce:indexed-name>Zeng M.S.</ce:indexed-name> <ce:surname>Zeng</ce:surname> </author> <author seq="9"> <ce:initials>K.H.</ce:initials> <ce:indexed-name>Huang K.H.</ce:indexed-name> <ce:surname>Huang</ce:surname> </author> </ref-authors> <ref-sourcetitle>J Surg Oncol</ref-sourcetitle> <ref-publicationyear first="2008"/> <ref-volisspag> <voliss volume="97"/> <pagerange first="267" last="272"/> </ref-volisspag> </ref-info> <ref-fulltext>Liu JH, Song LB, Zhang X, Guo BH, Feng Y, Li XX, Liao WT, Zeng MS, Huang KH. Bmi-1 expression predicts prognosis for patients with gastric carcinoma. J Surg Oncol. 2008; 97: 267-72.</ref-fulltext> </reference> <reference id="23"> <ref-info> <ref-title> <ref-titletext>Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">34548663637</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>D.</ce:initials> <ce:indexed-name>Mihic-Probst D.</ce:indexed-name> <ce:surname>Mihic-Probst</ce:surname> </author> <author seq="2"> <ce:initials>A.</ce:initials> <ce:indexed-name>Kuster A.</ce:indexed-name> <ce:surname>Kuster</ce:surname> </author> <author seq="3"> <ce:initials>S.</ce:initials> <ce:indexed-name>Kilgus S.</ce:indexed-name> <ce:surname>Kilgus</ce:surname> </author> <author seq="4"> <ce:initials>B.</ce:initials> <ce:indexed-name>Bode-Lesniewska B.</ce:indexed-name> <ce:surname>Bode-Lesniewska</ce:surname> </author> <author seq="5"> <ce:initials>B.</ce:initials> <ce:indexed-name>Ingold-Heppner B.</ce:indexed-name> <ce:surname>Ingold-Heppner</ce:surname> </author> <author seq="6"> <ce:initials>C.</ce:initials> <ce:indexed-name>Leung C.</ce:indexed-name> <ce:surname>Leung</ce:surname> </author> <author seq="7"> <ce:initials>M.</ce:initials> <ce:indexed-name>Storz M.</ce:indexed-name> <ce:surname>Storz</ce:surname> </author> <author seq="8"> <ce:initials>B.</ce:initials> <ce:indexed-name>Seifert B.</ce:indexed-name> <ce:surname>Seifert</ce:surname> </author> <author seq="9"> <ce:initials>S.</ce:initials> <ce:indexed-name>Marino S.</ce:indexed-name> <ce:surname>Marino</ce:surname> </author> <author seq="10"> <ce:initials>P.</ce:initials> <ce:indexed-name>Schraml P.</ce:indexed-name> <ce:surname>Schraml</ce:surname> </author> <author seq="11"> <ce:initials>R.</ce:initials> <ce:indexed-name>Dummer R.</ce:indexed-name> <ce:surname>Dummer</ce:surname> </author> <author seq="12"> <ce:initials>H.</ce:initials> <ce:indexed-name>Moch H.</ce:indexed-name> <ce:surname>Moch</ce:surname> </author> </ref-authors> <ref-sourcetitle>Int J Cancer</ref-sourcetitle> <ref-publicationyear first="2007"/> <ref-volisspag> <voliss volume="121"/> <pagerange first="1764" last="1770"/> </ref-volisspag> </ref-info> <ref-fulltext>Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C, Storz M, Seifert B, Marino S, Schraml P, Dummer R, Moch H. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer. 2007; 121: 1764-70.</ref-fulltext> </reference> <reference id="24"> <ref-info> <ref-title> <ref-titletext>Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in non-small cell lung cancers and their clinical and clinicopathologic significance</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">77953978709</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>J.</ce:initials> <ce:indexed-name>Kikuchi J.</ce:indexed-name> <ce:surname>Kikuchi</ce:surname> </author> <author seq="2"> <ce:initials>I.</ce:initials> <ce:indexed-name>Kinoshita I.</ce:indexed-name> <ce:surname>Kinoshita</ce:surname> </author> <author seq="3"> <ce:initials>Y.</ce:initials> <ce:indexed-name>Shimizu Y.</ce:indexed-name> <ce:surname>Shimizu</ce:surname> </author> <author seq="4"> <ce:initials>E.</ce:initials> <ce:indexed-name>Kikuchi E.</ce:indexed-name> <ce:surname>Kikuchi</ce:surname> </author> <author seq="5"> <ce:initials>J.</ce:initials> <ce:indexed-name>Konishi J.</ce:indexed-name> <ce:surname>Konishi</ce:surname> </author> <author seq="6"> <ce:initials>S.</ce:initials> <ce:indexed-name>Oizumi S.</ce:indexed-name> <ce:surname>Oizumi</ce:surname> </author> <author seq="7"> <ce:initials>K.</ce:initials> <ce:indexed-name>Kaga K.</ce:indexed-name> <ce:surname>Kaga</ce:surname> </author> <author seq="8"> <ce:initials>Y.</ce:initials> <ce:indexed-name>Matsuno Y.</ce:indexed-name> <ce:surname>Matsuno</ce:surname> </author> <author seq="9"> <ce:initials>M.</ce:initials> <ce:indexed-name>Nishimura M.</ce:indexed-name> <ce:surname>Nishimura</ce:surname> </author> <author seq="10"> <ce:initials>H.</ce:initials> <ce:indexed-name>Dosaka-Akita H.</ce:indexed-name> <ce:surname>Dosaka-Akita</ce:surname> </author> </ref-authors> <ref-sourcetitle>Cancer</ref-sourcetitle> <ref-publicationyear first="2010"/> <ref-volisspag> <voliss volume="116"/> <pagerange first="3015" last="3024"/> </ref-volisspag> </ref-info> <ref-fulltext>Kikuchi J, Kinoshita I, Shimizu Y, Kikuchi E, Konishi J, Oizumi S, Kaga K, Matsuno Y, Nishimura M, Dosaka-Akita H. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in non-small cell lung cancers and their clinical and clinicopathologic significance. Cancer. 2010; 116: 3015-24.</ref-fulltext> </reference> <reference id="25"> <ref-info> <ref-title> <ref-titletext>Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">79251589918</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>B.H.</ce:initials> <ce:indexed-name>Guo B.H.</ce:indexed-name> <ce:surname>Guo</ce:surname> </author> <author seq="2"> <ce:initials>Y.</ce:initials> <ce:indexed-name>Feng Y.</ce:indexed-name> <ce:surname>Feng</ce:surname> </author> <author seq="3"> <ce:initials>R.</ce:initials> <ce:indexed-name>Zhang R.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="4"> <ce:initials>L.H.</ce:initials> <ce:indexed-name>Xu L.H.</ce:indexed-name> <ce:surname>Xu</ce:surname> </author> <author seq="5"> <ce:initials>M.Z.</ce:initials> <ce:indexed-name>Li M.Z.</ce:indexed-name> <ce:surname>Li</ce:surname> </author> <author seq="6"> <ce:initials>H.F.</ce:initials> <ce:indexed-name>Kung H.F.</ce:indexed-name> <ce:surname>Kung</ce:surname> </author> <author seq="7"> <ce:initials>L.B.</ce:initials> <ce:indexed-name>Song L.B.</ce:indexed-name> <ce:surname>Song</ce:surname> </author> <author seq="8"> <ce:initials>M.S.</ce:initials> <ce:indexed-name>Zeng M.S.</ce:indexed-name> <ce:surname>Zeng</ce:surname> </author> </ref-authors> <ref-sourcetitle>Mol Cancer</ref-sourcetitle> <ref-publicationyear first="2011"/> <ref-volisspag> <voliss volume="10"/> <pagerange first="10"/> </ref-volisspag> </ref-info> <ref-fulltext>Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF, Song LB, Zeng MS. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer. 2011; 10: 10.</ref-fulltext> </reference> <reference id="26"> <ref-info> <ref-title> <ref-titletext>BMI1, ALDH1A1, and CD133 transcripts connect epithelial-mesenchymal transition to cancer stem cells in lung carcinoma</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="ARTNUM">9714315</itemid> <itemid idtype="SGR">84953332256</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>A.</ce:initials> <ce:indexed-name>Koren A.</ce:indexed-name> <ce:surname>Koren</ce:surname> </author> <author seq="2"> <ce:initials>M.</ce:initials> <ce:indexed-name>Rijavec M.</ce:indexed-name> <ce:surname>Rijavec</ce:surname> </author> <author seq="3"> <ce:initials>I.</ce:initials> <ce:indexed-name>Kern I.</ce:indexed-name> <ce:surname>Kern</ce:surname> </author> <author seq="4"> <ce:initials>E.</ce:initials> <ce:indexed-name>Sodja E.</ce:indexed-name> <ce:surname>Sodja</ce:surname> </author> <author seq="5"> <ce:initials>P.</ce:initials> <ce:indexed-name>Korosec P.</ce:indexed-name> <ce:surname>Korosec</ce:surname> </author> <author seq="6"> <ce:initials>T.</ce:initials> <ce:indexed-name>Cufer T.</ce:indexed-name> <ce:surname>Cufer</ce:surname> </author> </ref-authors> <ref-sourcetitle>Stem Cells Int</ref-sourcetitle> <ref-publicationyear first="2016"/> <ref-volisspag> <voliss volume="2016"/> </ref-volisspag> </ref-info> <ref-fulltext>Koren A, Rijavec M, Kern I, Sodja E, Korosec P, Cufer T. BMI1, ALDH1A1, and CD133 transcripts connect epithelial-mesenchymal transition to cancer stem cells in lung carcinoma. Stem Cells Int. 2016; 2016: 9714315.</ref-fulltext> </reference> <reference id="27"> <ref-info> <ref-title> <ref-titletext>The bmi-1 oncoprotein is differentially expressed in nonsmall cell lung cancer and correlates with INK4A-ARF locus expression</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">0035906853</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>S.</ce:initials> <ce:indexed-name>Vonlanthen S.</ce:indexed-name> <ce:surname>Vonlanthen</ce:surname> </author> <author seq="2"> <ce:initials>J.</ce:initials> <ce:indexed-name>Heighway J.</ce:indexed-name> <ce:surname>Heighway</ce:surname> </author> <author seq="3"> <ce:initials>H.J.</ce:initials> <ce:indexed-name>Altermatt H.J.</ce:indexed-name> <ce:surname>Altermatt</ce:surname> </author> <author seq="4"> <ce:initials>M.</ce:initials> <ce:indexed-name>Gugger M.</ce:indexed-name> <ce:surname>Gugger</ce:surname> </author> <author seq="5"> <ce:initials>A.</ce:initials> <ce:indexed-name>Kappeler A.</ce:indexed-name> <ce:surname>Kappeler</ce:surname> </author> <author seq="6"> <ce:initials>M.M.</ce:initials> <ce:indexed-name>Borner M.M.</ce:indexed-name> <ce:surname>Borner</ce:surname> </author> <author seq="7"> <ce:initials>M.</ce:initials> <ce:indexed-name>van Lohuizen M.</ce:indexed-name> <ce:surname>van Lohuizen</ce:surname> </author> <author seq="8"> <ce:initials>D.C.</ce:initials> <ce:indexed-name>Betticher D.C.</ce:indexed-name> <ce:surname>Betticher</ce:surname> </author> </ref-authors> <ref-sourcetitle>Br J Cancer</ref-sourcetitle> <ref-publicationyear first="2001"/> <ref-volisspag> <voliss volume="84"/> <pagerange first="1372" last="1376"/> </ref-volisspag> </ref-info> <ref-fulltext>Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van Lohuizen M, Betticher DC. The bmi-1 oncoprotein is differentially expressed in nonsmall cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer. 2001; 84: 1372-6.</ref-fulltext> </reference> <reference id="28"> <ref-info> <ref-title> <ref-titletext>IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84894476840</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>X.</ce:initials> <ce:indexed-name>Zhang X.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="2"> <ce:initials>J.</ce:initials> <ce:indexed-name>Sun J.</ce:indexed-name> <ce:surname>Sun</ce:surname> </author> <author seq="3"> <ce:initials>H.</ce:initials> <ce:indexed-name>Wang H.</ce:indexed-name> <ce:surname>Wang</ce:surname> </author> <author seq="4"> <ce:initials>Y.</ce:initials> <ce:indexed-name>Lou Y.</ce:indexed-name> <ce:surname>Lou</ce:surname> </author> <author seq="5"> <ce:initials>Y.</ce:initials> <ce:indexed-name>Zhang Y.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="6"> <ce:initials>H.</ce:initials> <ce:indexed-name>Sha H.</ce:indexed-name> <ce:surname>Sha</ce:surname> </author> <author seq="7"> <ce:initials>J.</ce:initials> <ce:indexed-name>Feng J.</ce:indexed-name> <ce:surname>Feng</ce:surname> </author> <author seq="8"> <ce:initials>B.</ce:initials> <ce:indexed-name>Han B.</ce:indexed-name> <ce:surname>Han</ce:surname> </author> </ref-authors> <ref-sourcetitle>Tumor Biol</ref-sourcetitle> <ref-publicationyear first="2014"/> <ref-volisspag> <voliss volume="35"/> <pagerange first="739" last="745"/> </ref-volisspag> </ref-info> <ref-fulltext>Zhang X, Sun J, Wang H, Lou Y, Zhang Y, Sha H, Feng J, Han B. IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance. Tumor Biol. 2014; 35: 739-45.</ref-fulltext> </reference> <reference id="29"> <ref-info> <ref-title> <ref-titletext>Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">49649083394</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>K.</ce:initials> <ce:indexed-name>Vrzalikova K.</ce:indexed-name> <ce:surname>Vrzalikova</ce:surname> </author> <author seq="2"> <ce:initials>J.</ce:initials> <ce:indexed-name>Skarda J.</ce:indexed-name> <ce:surname>Skarda</ce:surname> </author> <author seq="3"> <ce:initials>J.</ce:initials> <ce:indexed-name>Ehrmann J.</ce:indexed-name> <ce:surname>Ehrmann</ce:surname> </author> <author seq="4"> <ce:initials>P.G.</ce:initials> <ce:indexed-name>Murray P.G.</ce:indexed-name> <ce:surname>Murray</ce:surname> </author> <author seq="5"> <ce:initials>E.</ce:initials> <ce:indexed-name>Fridman E.</ce:indexed-name> <ce:surname>Fridman</ce:surname> </author> <author seq="6"> <ce:initials>J.</ce:initials> <ce:indexed-name>Kopolovic J.</ce:indexed-name> <ce:surname>Kopolovic</ce:surname> </author> <author seq="7"> <ce:initials>P.</ce:initials> <ce:indexed-name>Knizetova P.</ce:indexed-name> <ce:surname>Knizetova</ce:surname> </author> <author seq="8"> <ce:initials>M.</ce:initials> <ce:indexed-name>Hajduch M.</ce:indexed-name> <ce:surname>Hajduch</ce:surname> </author> <author seq="9"> <ce:initials>J.</ce:initials> <ce:indexed-name>Klein J.</ce:indexed-name> <ce:surname>Klein</ce:surname> </author> <author seq="10"> <ce:initials>V.</ce:initials> <ce:indexed-name>Kolek V.</ce:indexed-name> <ce:surname>Kolek</ce:surname> </author> <author seq="11"> <ce:initials>L.</ce:initials> <ce:indexed-name>Radova L.</ce:indexed-name> <ce:surname>Radova</ce:surname> </author> <author seq="12"> <ce:initials>Z.</ce:initials> <ce:indexed-name>Kolar Z.</ce:indexed-name> <ce:surname>Kolar</ce:surname> </author> </ref-authors> <ref-sourcetitle>J Cancer Res Clin Oncol</ref-sourcetitle> <ref-publicationyear first="2008"/> <ref-volisspag> <voliss volume="134"/> <pagerange first="1037" last="1042"/> </ref-volisspag> </ref-info> <ref-fulltext>Vrzalikova K, Skarda J, Ehrmann J, Murray PG, Fridman E, Kopolovic J, Knizetova P, Hajduch M, Klein J, Kolek V, Radova L, Kolar Z. Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. J Cancer Res Clin Oncol. 2008; 134: 1037-42.</ref-fulltext> </reference> <reference id="30"> <ref-info> <ref-title> <ref-titletext>An embryonic stem cell-like signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinoma</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">70350222208</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>K.A.</ce:initials> <ce:indexed-name>Hassan K.A.</ce:indexed-name> <ce:surname>Hassan</ce:surname> </author> <author seq="2"> <ce:initials>G.</ce:initials> <ce:indexed-name>Chen G.</ce:indexed-name> <ce:surname>Chen</ce:surname> </author> <author seq="3"> <ce:initials>G.P.</ce:initials> <ce:indexed-name>Kalemkerian G.P.</ce:indexed-name> <ce:surname>Kalemkerian</ce:surname> </author> <author seq="4"> <ce:initials>M.S.</ce:initials> <ce:indexed-name>Wicha M.S.</ce:indexed-name> <ce:surname>Wicha</ce:surname> </author> <author seq="5"> <ce:initials>D.G.</ce:initials> <ce:indexed-name>Beer D.G.</ce:indexed-name> <ce:surname>Beer</ce:surname> </author> </ref-authors> <ref-sourcetitle>Clin Cancer Res</ref-sourcetitle> <ref-publicationyear first="2009"/> <ref-volisspag> <voliss volume="15"/> <pagerange first="6386" last="6390"/> </ref-volisspag> </ref-info> <ref-fulltext>Hassan KA, Chen G, Kalemkerian GP, Wicha MS, Beer DG. An embryonic stem cell-like signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinoma. Clin Cancer Res. 2009; 15: 6386-90.</ref-fulltext> </reference> <reference id="31"> <ref-info> <ref-title> <ref-titletext>Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84860222900</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>X.</ce:initials> <ce:indexed-name>Zhang X.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="2"> <ce:initials>C.</ce:initials> <ce:indexed-name>Wang C.</ce:indexed-name> <ce:surname>Wang</ce:surname> </author> <author seq="3"> <ce:initials>L.</ce:initials> <ce:indexed-name>Wang L.</ce:indexed-name> <ce:surname>Wang</ce:surname> </author> <author seq="4"> <ce:initials>L.</ce:initials> <ce:indexed-name>Du L.</ce:indexed-name> <ce:surname>Du</ce:surname> </author> <author seq="5"> <ce:initials>S.</ce:initials> <ce:indexed-name>Wang S.</ce:indexed-name> <ce:surname>Wang</ce:surname> </author> <author seq="6"> <ce:initials>G.</ce:initials> <ce:indexed-name>Zheng G.</ce:indexed-name> <ce:surname>Zheng</ce:surname> </author> <author seq="7"> <ce:initials>W.</ce:initials> <ce:indexed-name>Li W.</ce:indexed-name> <ce:surname>Li</ce:surname> </author> <author seq="8"> <ce:initials>X.</ce:initials> <ce:indexed-name>Zhuang X.</ce:indexed-name> <ce:surname>Zhuang</ce:surname> </author> <author seq="9"> <ce:initials>X.</ce:initials> <ce:indexed-name>Zhang X.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="10"> <ce:initials>Z.</ce:initials> <ce:indexed-name>Dong Z.</ce:indexed-name> <ce:surname>Dong</ce:surname> </author> </ref-authors> <ref-sourcetitle>Int J Cancer</ref-sourcetitle> <ref-publicationyear first="2012"/> <ref-volisspag> <voliss volume="131"/> <pagerange first="165" last="172"/> </ref-volisspag> </ref-info> <ref-fulltext>Zhang X, Wang C, Wang L, Du L, Wang S, Zheng G, Li W, Zhuang X, Zhang X, Dong Z. Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer. Int J Cancer. 2012; 131: 165-72.</ref-fulltext> </reference> <reference id="32"> <ref-info> <ref-title> <ref-titletext>Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="ARTNUM">R55</itemid> <itemid idtype="SGR">36549060556</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>J.</ce:initials> <ce:indexed-name>Silva J.</ce:indexed-name> <ce:surname>Silva</ce:surname> </author> <author seq="2"> <ce:initials>V.</ce:initials> <ce:indexed-name>Garcia V.</ce:indexed-name> <ce:surname>García</ce:surname> </author> <author seq="3"> <ce:initials>J.M.</ce:initials> <ce:indexed-name>Garcia J.M.</ce:indexed-name> <ce:surname>García</ce:surname> </author> <author seq="4"> <ce:initials>C.</ce:initials> <ce:indexed-name>Pena C.</ce:indexed-name> <ce:surname>Peña</ce:surname> </author> <author seq="5"> <ce:initials>G.</ce:initials> <ce:indexed-name>Dominguez G.</ce:indexed-name> <ce:surname>Domínguez</ce:surname> </author> <author seq="6"> <ce:initials>R.</ce:initials> <ce:indexed-name>Diaz R.</ce:indexed-name> <ce:surname>Díaz</ce:surname> </author> <author seq="7"> <ce:initials>Y.</ce:initials> <ce:indexed-name>Lorenzo Y.</ce:indexed-name> <ce:surname>Lorenzo</ce:surname> </author> <author seq="8"> <ce:initials>A.</ce:initials> <ce:indexed-name>Hurtado A.</ce:indexed-name> <ce:surname>Hurtado</ce:surname> </author> <author seq="9"> <ce:initials>A.</ce:initials> <ce:indexed-name>Sanchez A.</ce:indexed-name> <ce:surname>Sánchez</ce:surname> </author> <author seq="10"> <ce:initials>F.</ce:initials> <ce:indexed-name>Bonilla F.</ce:indexed-name> <ce:surname>Bonilla</ce:surname> </author> </ref-authors> <ref-sourcetitle>Breast Cancer Res</ref-sourcetitle> <ref-publicationyear first="2007"/> <ref-volisspag> <voliss volume="9"/> </ref-volisspag> </ref-info> <ref-fulltext>Silva J, García V, García JM, Peña C, Domínguez G, Díaz R, Lorenzo Y, Hurtado A, Sánchez A, Bonilla F. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast Cancer Res. 2007; 9: R55.</ref-fulltext> </reference> <reference id="33"> <ref-info> <ref-title> <ref-titletext>Distinct BMI-1 and EZH2 Expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T Cell differentiation</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">0035873747</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>F.M.</ce:initials> <ce:indexed-name>Raaphorst F.M.</ce:indexed-name> <ce:surname>Raaphorst</ce:surname> </author> <author seq="2"> <ce:initials>A.P.</ce:initials> <ce:indexed-name>Otte A.P.</ce:indexed-name> <ce:surname>Otte</ce:surname> </author> <author seq="3"> <ce:initials>F.J.</ce:initials> <ce:indexed-name>van Kemenade F.J.</ce:indexed-name> <ce:surname>van Kemenade</ce:surname> </author> <author seq="4"> <ce:initials>T.</ce:initials> <ce:indexed-name>Blokzijl T.</ce:indexed-name> <ce:surname>Blokzijl</ce:surname> </author> <author seq="5"> <ce:initials>E.</ce:initials> <ce:indexed-name>Fieret E.</ce:indexed-name> <ce:surname>Fieret</ce:surname> </author> <author seq="6"> <ce:initials>K.M.</ce:initials> <ce:indexed-name>Hamer K.M.</ce:indexed-name> <ce:surname>Hamer</ce:surname> </author> <author seq="7"> <ce:initials>D.P.E.</ce:initials> <ce:indexed-name>Satijn D.P.E.</ce:indexed-name> <ce:surname>Satijn</ce:surname> </author> <author seq="8"> <ce:initials>C.J.L.M.</ce:initials> <ce:indexed-name>Meijer C.J.L.M.</ce:indexed-name> <ce:surname>Meijer</ce:surname> </author> </ref-authors> <ref-sourcetitle>J Immunol</ref-sourcetitle> <ref-publicationyear first="2001"/> <ref-volisspag> <voliss volume="166"/> <pagerange first="5925" last="5934"/> </ref-volisspag> </ref-info> <ref-fulltext>Raaphorst FM, Otte AP, van Kemenade FJ, Blokzijl T, Fieret E, Hamer KM, Satijn DPE, Meijer CJLM. Distinct BMI-1 and EZH2 Expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T Cell differentiation. J Immunol. 2001; 166: 5925-34.</ref-fulltext> </reference> <reference id="34"> <ref-info> <ref-title> <ref-titletext>Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">41049109184</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>H.</ce:initials> <ce:indexed-name>Wang H.</ce:indexed-name> <ce:surname>Wang</ce:surname> </author> <author seq="2"> <ce:initials>K.</ce:initials> <ce:indexed-name>Pan K.</ce:indexed-name> <ce:surname>Pan</ce:surname> </author> <author seq="3"> <ce:initials>H.</ce:initials> <ce:indexed-name>Zhang H.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="4"> <ce:initials>D.</ce:initials> <ce:indexed-name>Weng D.</ce:indexed-name> <ce:surname>Weng</ce:surname> </author> <author seq="5"> <ce:initials>J.</ce:initials> <ce:indexed-name>Zhou J.</ce:indexed-name> <ce:surname>Zhou</ce:surname> </author> <author seq="6"> <ce:initials>J.</ce:initials> <ce:indexed-name>Li J.</ce:indexed-name> <ce:surname>Li</ce:surname> </author> <author seq="7"> <ce:initials>W.</ce:initials> <ce:indexed-name>Huang W.</ce:indexed-name> <ce:surname>Huang</ce:surname> </author> <author seq="8"> <ce:initials>H.</ce:initials> <ce:indexed-name>Song H.</ce:indexed-name> <ce:surname>Song</ce:surname> </author> <author seq="9"> <ce:initials>M.</ce:initials> <ce:indexed-name>Chen M.</ce:indexed-name> <ce:surname>Chen</ce:surname> </author> <author seq="10"> <ce:initials>J.</ce:initials> <ce:indexed-name>Xia J.</ce:indexed-name> <ce:surname>Xia</ce:surname> </author> </ref-authors> <ref-sourcetitle>J Cancer Res Clin Oncol</ref-sourcetitle> <ref-publicationyear first="2008"/> <ref-volisspag> <voliss volume="134"/> <pagerange first="535" last="541"/> </ref-volisspag> </ref-info> <ref-fulltext>Wang H, Pan K, Zhang H, Weng D, Zhou J, Li J, Huang W, Song H, Chen M, Xia J. Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2008; 134: 535-41.</ref-fulltext> </reference> <reference id="35"> <ref-info> <ref-title> <ref-titletext>Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">58049206889</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>Y.J.</ce:initials> <ce:indexed-name>Choi Y.J.</ce:indexed-name> <ce:surname>Choi</ce:surname> </author> <author seq="2"> <ce:initials>Y.L.</ce:initials> <ce:indexed-name>Choi Y.L.</ce:indexed-name> <ce:surname>Choi</ce:surname> </author> <author seq="3"> <ce:initials>E.Y.</ce:initials> <ce:indexed-name>Cho E.Y.</ce:indexed-name> <ce:surname>Cho</ce:surname> </author> <author seq="4"> <ce:initials>Y.K.</ce:initials> <ce:indexed-name>Shin Y.K.</ce:indexed-name> <ce:surname>Shin</ce:surname> </author> <author seq="5"> <ce:initials>K.W.</ce:initials> <ce:indexed-name>Sung K.W.</ce:indexed-name> <ce:surname>Sung</ce:surname> </author> <author seq="6"> <ce:initials>Y.K.</ce:initials> <ce:indexed-name>Hwang Y.K.</ce:indexed-name> <ce:surname>Hwang</ce:surname> </author> <author seq="7"> <ce:initials>S.J.</ce:initials> <ce:indexed-name>Lee S.J.</ce:indexed-name> <ce:surname>Lee</ce:surname> </author> <author seq="8"> <ce:initials>G.</ce:initials> <ce:indexed-name>Kong G.</ce:indexed-name> <ce:surname>Kong</ce:surname> </author> <author seq="9"> <ce:initials>J.E.</ce:initials> <ce:indexed-name>Lee J.E.</ce:indexed-name> <ce:surname>Lee</ce:surname> </author> <author seq="10"> <ce:initials>J.S.</ce:initials> <ce:indexed-name>Kim J.S.</ce:indexed-name> <ce:surname>Kim</ce:surname> </author> <author seq="11"> <ce:initials>J.H.</ce:initials> <ce:indexed-name>Kim J.H.</ce:indexed-name> <ce:surname>Kim</ce:surname> </author> <author seq="12"> <ce:initials>J.H.</ce:initials> <ce:indexed-name>Yang J.H.</ce:indexed-name> <ce:surname>Yang</ce:surname> </author> <author seq="13"> <ce:initials>S.J.</ce:initials> <ce:indexed-name>Nam S.J.</ce:indexed-name> <ce:surname>Nam</ce:surname> </author> </ref-authors> <ref-sourcetitle>Breast Cancer Res Treat</ref-sourcetitle> <ref-publicationyear first="2009"/> <ref-volisspag> <voliss volume="113"/> <pagerange first="83" last="93"/> </ref-volisspag> </ref-info> <ref-fulltext>Choi YJ, Choi YL, Cho EY, Shin YK, Sung KW, Hwang YK, Lee SJ, Kong G, Lee JE, Kim JS, Kim JH, Yang JH, Nam SJ. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients. Breast Cancer Res Treat. 2009; 113: 83-93.</ref-fulltext> </reference> <reference id="36"> <ref-info> <ref-title> <ref-titletext>EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="ARTNUM">R109</itemid> <itemid idtype="SGR">63849258988</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>A.M.</ce:initials> <ce:indexed-name>Pietersen A.M.</ce:indexed-name> <ce:surname>Pietersen</ce:surname> </author> <author seq="2"> <ce:initials>H.M.</ce:initials> <ce:indexed-name>Horlings H.M.</ce:indexed-name> <ce:surname>Horlings</ce:surname> </author> <author seq="3"> <ce:initials>M.</ce:initials> <ce:indexed-name>Hauptmann M.</ce:indexed-name> <ce:surname>Hauptmann</ce:surname> </author> <author seq="4"> <ce:initials>A.</ce:initials> <ce:indexed-name>Langerod A.</ce:indexed-name> <ce:surname>Langerød</ce:surname> </author> <author seq="5"> <ce:initials>A.</ce:initials> <ce:indexed-name>Ajouaou A.</ce:indexed-name> <ce:surname>Ajouaou</ce:surname> </author> <author seq="6"> <ce:initials>P.</ce:initials> <ce:indexed-name>Cornelissen-Steijger P.</ce:indexed-name> <ce:surname>Cornelissen-Steijger</ce:surname> </author> <author seq="7"> <ce:initials>L.F.</ce:initials> <ce:indexed-name>Wessels L.F.</ce:indexed-name> <ce:surname>Wessels</ce:surname> </author> <author seq="8"> <ce:initials>J.</ce:initials> <ce:indexed-name>Jonkers J.</ce:indexed-name> <ce:surname>Jonkers</ce:surname> </author> <author seq="9"> <ce:initials>M.J.</ce:initials> <ce:indexed-name>van de Vijver M.J.</ce:indexed-name> <ce:surname>van de Vijver</ce:surname> </author> <author seq="10"> <ce:initials>M.</ce:initials> <ce:indexed-name>van Lohuizen M.</ce:indexed-name> <ce:surname>van Lohuizen</ce:surname> </author> </ref-authors> <ref-sourcetitle>Breast Cancer Res</ref-sourcetitle> <ref-publicationyear first="2008"/> <ref-volisspag> <voliss volume="10"/> </ref-volisspag> </ref-info> <ref-fulltext>Pietersen AM, Horlings HM, Hauptmann M, Langerød A, Ajouaou A, Cornelissen-Steijger P, Wessels LF, Jonkers J, van de Vijver MJ, van Lohuizen M. EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer. Breast Cancer Res. 2008; 10: R109.</ref-fulltext> </reference> <reference id="37"> <ref-info> <ref-title> <ref-titletext>Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84865409285</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>T.</ce:initials> <ce:indexed-name>Cenci T.</ce:indexed-name> <ce:surname>Cenci</ce:surname> </author> <author seq="2"> <ce:initials>M.</ce:initials> <ce:indexed-name>Martini M.</ce:indexed-name> <ce:surname>Martini</ce:surname> </author> <author seq="3"> <ce:initials>N.</ce:initials> <ce:indexed-name>Montano N.</ce:indexed-name> <ce:surname>Montano</ce:surname> </author> <author seq="4"> <ce:initials>Q.G.</ce:initials> <ce:indexed-name>D'Alessandris Q.G.</ce:indexed-name> <ce:surname>D'Alessandris</ce:surname> </author> <author seq="5"> <ce:initials>M.L.</ce:initials> <ce:indexed-name>Falchetti M.L.</ce:indexed-name> <ce:surname>Falchetti</ce:surname> </author> <author seq="6"> <ce:initials>D.</ce:initials> <ce:indexed-name>Annibali D.</ce:indexed-name> <ce:surname>Annibali</ce:surname> </author> <author seq="7"> <ce:initials>M.</ce:initials> <ce:indexed-name>Savino M.</ce:indexed-name> <ce:surname>Savino</ce:surname> </author> <author seq="8"> <ce:initials>F.</ce:initials> <ce:indexed-name>Bianchi F.</ce:indexed-name> <ce:surname>Bianchi</ce:surname> </author> <author seq="9"> <ce:initials>F.</ce:initials> <ce:indexed-name>Pierconti F.</ce:indexed-name> <ce:surname>Pierconti</ce:surname> </author> <author seq="10"> <ce:initials>S.</ce:initials> <ce:indexed-name>Nasi S.</ce:indexed-name> <ce:surname>Nasi</ce:surname> </author> <author seq="11"> <ce:initials>R.</ce:initials> <ce:indexed-name>Pallini R.</ce:indexed-name> <ce:surname>Pallini</ce:surname> </author> <author seq="12"> <ce:initials>L.M.</ce:initials> <ce:indexed-name>Larocca L.M.</ce:indexed-name> <ce:surname>Larocca</ce:surname> </author> </ref-authors> <ref-sourcetitle>Am J Clin Pathol</ref-sourcetitle> <ref-publicationyear first="2012"/> <ref-volisspag> <voliss volume="138"/> <pagerange first="390" last="396"/> </ref-volisspag> </ref-info> <ref-fulltext>Cenci T, Martini M, Montano N, D'Alessandris QG, Falchetti ML, Annibali D, Savino M, Bianchi F, Pierconti F, Nasi S, Pallini R, Larocca LM. Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma. Am J Clin Pathol. 2012; 138: 390-6.</ref-fulltext> </reference> <reference id="38"> <ref-info> <ref-title> <ref-titletext>Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84949293601</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>J.</ce:initials> <ce:indexed-name>Su J.</ce:indexed-name> <ce:surname>Su</ce:surname> </author> <author seq="2"> <ce:initials>S.</ce:initials> <ce:indexed-name>Wu S.</ce:indexed-name> <ce:surname>Wu</ce:surname> </author> <author seq="3"> <ce:initials>W.</ce:initials> <ce:indexed-name>Tang W.</ce:indexed-name> <ce:surname>Tang</ce:surname> </author> <author seq="4"> <ce:initials>H.</ce:initials> <ce:indexed-name>Qian H.</ce:indexed-name> <ce:surname>Qian</ce:surname> </author> <author seq="5"> <ce:initials>H.</ce:initials> <ce:indexed-name>Zhou H.</ce:indexed-name> <ce:surname>Zhou</ce:surname> </author> <author seq="6"> <ce:initials>T.</ce:initials> <ce:indexed-name>Guo T.</ce:indexed-name> <ce:surname>Guo</ce:surname> </author> </ref-authors> <ref-sourcetitle>Mol Carcinog</ref-sourcetitle> <ref-publicationyear first="2015"/> <ref-volisspag> <voliss volume="55"/> <pagerange first="1822" last="1832"/> </ref-volisspag> </ref-info> <ref-fulltext>Su J, Wu S, Tang W, Qian H, Zhou H, Guo T. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling. Mol Carcinog. 2015; 55: 1822-32.</ref-fulltext> </reference> <reference id="39"> <ref-info> <ref-title> <ref-titletext>Ubiquitination and degradation of ribonucleotide reductase M1 by the polycomb group proteins RNF2 and Bmi1 and cellular response to gemcitabine</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="ARTNUM">e91186</itemid> <itemid idtype="SGR">84897492457</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>Y.</ce:initials> <ce:indexed-name>Zhang Y.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="2"> <ce:initials>X.</ce:initials> <ce:indexed-name>Li X.</ce:indexed-name> <ce:surname>Li</ce:surname> </author> <author seq="3"> <ce:initials>Z.</ce:initials> <ce:indexed-name>Chen Z.</ce:indexed-name> <ce:surname>Chen</ce:surname> </author> <author seq="4"> <ce:initials>G.</ce:initials> <ce:indexed-name>Bepler G.</ce:indexed-name> <ce:surname>Bepler</ce:surname> </author> </ref-authors> <ref-sourcetitle>PLoS One</ref-sourcetitle> <ref-publicationyear first="2014"/> <ref-volisspag> <voliss volume="9"/> </ref-volisspag> </ref-info> <ref-fulltext>Zhang Y, Li X, Chen Z, Bepler G. Ubiquitination and degradation of ribonucleotide reductase M1 by the polycomb group proteins RNF2 and Bmi1 and cellular response to gemcitabine. PLoS One. 2014; 9: e91186.</ref-fulltext> </reference> <reference id="40"> <ref-info> <ref-title> <ref-titletext>Pertubation of B and T cell development and predisposition to lymphomagenesis in Emu Bmi1 transgenic mice require the Bmi1 RING finger</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">0030611381</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>M.J.</ce:initials> <ce:indexed-name>Alkema M.J.</ce:indexed-name> <ce:surname>Alkema</ce:surname> </author> <author seq="2"> <ce:initials>H.</ce:initials> <ce:indexed-name>Jacobs H.</ce:indexed-name> <ce:surname>Jacobs</ce:surname> </author> <author seq="3"> <ce:initials>M.</ce:initials> <ce:indexed-name>van Lohuizen M.</ce:indexed-name> <ce:surname>van Lohuizen</ce:surname> </author> <author seq="4"> <ce:initials>A.</ce:initials> <ce:indexed-name>Berns A.</ce:indexed-name> <ce:surname>Berns</ce:surname> </author> </ref-authors> <ref-sourcetitle>Oncogene</ref-sourcetitle> <ref-publicationyear first="1997"/> <ref-volisspag> <voliss volume="15"/> <pagerange first="899" last="910"/> </ref-volisspag> </ref-info> <ref-fulltext>Alkema MJ, Jacobs H, van Lohuizen M, Berns A. Pertubation of B and T cell development and predisposition to lymphomagenesis in Emu Bmi1 transgenic mice require the Bmi1 RING finger. Oncogene. 1997; 15: 899-910.</ref-fulltext> </reference> <reference id="41"> <ref-info> <ref-title> <ref-titletext>Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">33746008541</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>Z.</ce:initials> <ce:indexed-name>Li Z.</ce:indexed-name> <ce:surname>Li</ce:surname> </author> <author seq="2"> <ce:initials>R.</ce:initials> <ce:indexed-name>Cao R.</ce:indexed-name> <ce:surname>Cao</ce:surname> </author> <author seq="3"> <ce:initials>M.</ce:initials> <ce:indexed-name>Wang M.</ce:indexed-name> <ce:surname>Wang</ce:surname> </author> <author seq="4"> <ce:initials>M.P.</ce:initials> <ce:indexed-name>Myers M.P.</ce:indexed-name> <ce:surname>Myers</ce:surname> </author> <author seq="5"> <ce:initials>Y.</ce:initials> <ce:indexed-name>Zhang Y.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="6"> <ce:initials>R.M.</ce:initials> <ce:indexed-name>Xu R.M.</ce:indexed-name> <ce:surname>Xu</ce:surname> </author> </ref-authors> <ref-sourcetitle>J Biol Chem</ref-sourcetitle> <ref-publicationyear first="2006"/> <ref-volisspag> <voliss volume="281"/> <pagerange first="20643" last="20649"/> </ref-volisspag> </ref-info> <ref-fulltext>Li Z, Cao R, Wang M, Myers MP, Zhang Y, Xu RM. Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex. J Biol Chem. 2006; 281: 20643-9.</ref-fulltext> </reference> <reference id="42"> <ref-info> <ref-title> <ref-titletext>Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP expression</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="ARTNUM">350ra104</itemid> <itemid idtype="SGR">84982795836</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>K.J.</ce:initials> <ce:indexed-name>Yong K.J.</ce:indexed-name> <ce:surname>Yong</ce:surname> </author> <author seq="2"> <ce:initials>D.S.</ce:initials> <ce:indexed-name>Basseres D.S.</ce:indexed-name> <ce:surname>Basseres</ce:surname> </author> <author seq="3"> <ce:initials>R.S.</ce:initials> <ce:indexed-name>Welner R.S.</ce:indexed-name> <ce:surname>Welner</ce:surname> </author> <author seq="4"> <ce:initials>W.C.</ce:initials> <ce:indexed-name>Zhang W.C.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="5"> <ce:initials>H.</ce:initials> <ce:indexed-name>Yang H.</ce:indexed-name> <ce:surname>Yang</ce:surname> </author> <author seq="6"> <ce:initials>B.</ce:initials> <ce:indexed-name>Yan B.</ce:indexed-name> <ce:surname>Yan</ce:surname> </author> <author seq="7"> <ce:initials>M.</ce:initials> <ce:indexed-name>Alberich-Jorda M.</ce:indexed-name> <ce:surname>Alberich-Jorda</ce:surname> </author> <author seq="8"> <ce:initials>J.</ce:initials> <ce:indexed-name>Zhang J.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <author seq="9"> <ce:initials>L.L.</ce:initials> <ce:indexed-name>de Figueiredo-Pontes L.L.</ce:indexed-name> <ce:surname>de Figueiredo-Pontes</ce:surname> </author> <author seq="10"> <ce:initials>C.</ce:initials> <ce:indexed-name>Battelli C.</ce:indexed-name> <ce:surname>Battelli</ce:surname> </author> <author seq="11"> <ce:initials>C.J.</ce:initials> <ce:indexed-name>Hetherington C.J.</ce:indexed-name> <ce:surname>Hetherington</ce:surname> </author> <author seq="12"> <ce:initials>M.</ce:initials> <ce:indexed-name>Ye M.</ce:indexed-name> <ce:surname>Ye</ce:surname> </author> <author seq="13"> <ce:initials>H.</ce:initials> <ce:indexed-name>Zhang H.</ce:indexed-name> <ce:surname>Zhang</ce:surname> </author> <et-al/> </ref-authors> <ref-sourcetitle>Sci Transl Med</ref-sourcetitle> <ref-publicationyear first="2016"/> <ref-volisspag> <voliss volume="8"/> </ref-volisspag> </ref-info> <ref-fulltext>Yong KJ, Basseres DS, Welner RS, Zhang WC, Yang H, Yan B, Alberich-Jorda M, Zhang J, de Figueiredo-Pontes LL, Battelli C, Hetherington CJ, Ye M, Zhang H, et al. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP expression. Sci Transl Med. 2016; 8: 350ra104.</ref-fulltext> </reference> <reference id="43"> <ref-info> <ref-title> <ref-titletext>Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">33846850149</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>W.J.</ce:initials> <ce:indexed-name>Guo W.J.</ce:indexed-name> <ce:surname>Guo</ce:surname> </author> <author seq="2"> <ce:initials>S.</ce:initials> <ce:indexed-name>Datta S.</ce:indexed-name> <ce:surname>Datta</ce:surname> </author> <author seq="3"> <ce:initials>V.</ce:initials> <ce:indexed-name>Band V.</ce:indexed-name> <ce:surname>Band</ce:surname> </author> <author seq="4"> <ce:initials>G.P.</ce:initials> <ce:indexed-name>Dimri G.P.</ce:indexed-name> <ce:surname>Dimri</ce:surname> </author> </ref-authors> <ref-sourcetitle>Mol Biol Cell</ref-sourcetitle> <ref-publicationyear first="2007"/> <ref-volisspag> <voliss volume="18"/> <pagerange first="536" last="546"/> </ref-volisspag> </ref-info> <ref-fulltext>Guo WJ, Datta S, Band V, Dimri GP. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell. 2007; 18: 536-46.</ref-fulltext> </reference> <reference id="44"> <ref-info> <ref-title> <ref-titletext>BMI1 as oncogenic candidate in a novel TCRB-associated chromosomal aberration in a patient with TCRgammadelta+ T-cell acute lymphoblastic leukemia</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">45149127503</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>N.S.D.</ce:initials> <ce:indexed-name>Larmonie N.S.D.</ce:indexed-name> <ce:surname>Larmonie</ce:surname> </author> <author seq="2"> <ce:initials>W.A.</ce:initials> <ce:indexed-name>Dik W.A.</ce:indexed-name> <ce:surname>Dik</ce:surname> </author> <author seq="3"> <ce:initials>H.B.</ce:initials> <ce:indexed-name>Beverloo H.B.</ce:indexed-name> <ce:surname>Beverloo</ce:surname> </author> <author seq="4"> <ce:initials>E.R.</ce:initials> <ce:indexed-name>van Wering E.R.</ce:indexed-name> <ce:surname>van Wering</ce:surname> </author> <author seq="5"> <ce:initials>J.J.M.</ce:initials> <ce:indexed-name>van Dongen J.J.M.</ce:indexed-name> <ce:surname>van Dongen</ce:surname> </author> <author seq="6"> <ce:initials>A.W.</ce:initials> <ce:indexed-name>Langerak A.W.</ce:indexed-name> <ce:surname>Langerak</ce:surname> </author> </ref-authors> <ref-sourcetitle>Leukemia</ref-sourcetitle> <ref-publicationyear first="2008"/> <ref-volisspag> <voliss volume="22"/> <pagerange first="1266" last="1267"/> </ref-volisspag> </ref-info> <ref-fulltext>Larmonie NSD, Dik WA, Beverloo HB, van Wering ER, van Dongen JJM, Langerak AW. BMI1 as oncogenic candidate in a novel TCRB-associated chromosomal aberration in a patient with TCRgammadelta+ T-cell acute lymphoblastic leukemia. Leukemia. 2008; 22: 1266-7.</ref-fulltext> </reference> <reference id="45"> <ref-info> <ref-title> <ref-titletext>New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">57849117384</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>E.A.</ce:initials> <ce:indexed-name>Eisenhauer E.A.</ce:indexed-name> <ce:surname>Eisenhauer</ce:surname> </author> <author seq="2"> <ce:initials>P.</ce:initials> <ce:indexed-name>Therasse P.</ce:indexed-name> <ce:surname>Therasse</ce:surname> </author> <author seq="3"> <ce:initials>J.</ce:initials> <ce:indexed-name>Bogaerts J.</ce:indexed-name> <ce:surname>Bogaerts</ce:surname> </author> <author seq="4"> <ce:initials>L.H.</ce:initials> <ce:indexed-name>Schwartz L.H.</ce:indexed-name> <ce:surname>Schwartz</ce:surname> </author> <author seq="5"> <ce:initials>D.</ce:initials> <ce:indexed-name>Sargent D.</ce:indexed-name> <ce:surname>Sargent</ce:surname> </author> <author seq="6"> <ce:initials>R.</ce:initials> <ce:indexed-name>Ford R.</ce:indexed-name> <ce:surname>Ford</ce:surname> </author> <author seq="7"> <ce:initials>J.</ce:initials> <ce:indexed-name>Dancey J.</ce:indexed-name> <ce:surname>Dancey</ce:surname> </author> <author seq="8"> <ce:initials>S.</ce:initials> <ce:indexed-name>Arbuck S.</ce:indexed-name> <ce:surname>Arbuck</ce:surname> </author> <author seq="9"> <ce:initials>S.</ce:initials> <ce:indexed-name>Gwyther S.</ce:indexed-name> <ce:surname>Gwyther</ce:surname> </author> <author seq="10"> <ce:initials>M.</ce:initials> <ce:indexed-name>Mooney M.</ce:indexed-name> <ce:surname>Mooney</ce:surname> </author> <author seq="11"> <ce:initials>L.</ce:initials> <ce:indexed-name>Rubinstein L.</ce:indexed-name> <ce:surname>Rubinstein</ce:surname> </author> <author seq="12"> <ce:initials>L.</ce:initials> <ce:indexed-name>Shankar L.</ce:indexed-name> <ce:surname>Shankar</ce:surname> </author> <author seq="13"> <ce:initials>L.</ce:initials> <ce:indexed-name>Dodd L.</ce:indexed-name> <ce:surname>Dodd</ce:surname> </author> <et-al/> </ref-authors> <ref-sourcetitle>Eur J Cancer</ref-sourcetitle> <ref-publicationyear first="2009"/> <ref-volisspag> <voliss volume="45"/> <pagerange first="228" last="247"/> </ref-volisspag> </ref-info> <ref-fulltext>Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009; 45: 228-47.</ref-fulltext> </reference> <reference id="46"> <ref-info> <ref-title> <ref-titletext>Toxicity and response criteria of the Eastern Cooperative Oncology Group</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">0020396015</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>M.M.</ce:initials> <ce:indexed-name>Oken M.M.</ce:indexed-name> <ce:surname>Oken</ce:surname> </author> <author seq="2"> <ce:initials>R.H.</ce:initials> <ce:indexed-name>Creech R.H.</ce:indexed-name> <ce:surname>Creech</ce:surname> </author> <author seq="3"> <ce:initials>D.C.</ce:initials> <ce:indexed-name>Tormey D.C.</ce:indexed-name> <ce:surname>Tormey</ce:surname> </author> <author seq="4"> <ce:initials>J.</ce:initials> <ce:indexed-name>Horton J.</ce:indexed-name> <ce:surname>Horton</ce:surname> </author> <author seq="5"> <ce:initials>T.E.</ce:initials> <ce:indexed-name>Davis T.E.</ce:indexed-name> <ce:surname>Davis</ce:surname> </author> <author seq="6"> <ce:initials>E.T.</ce:initials> <ce:indexed-name>McFadden E.T.</ce:indexed-name> <ce:surname>McFadden</ce:surname> </author> <author seq="7"> <ce:initials>P.P.</ce:initials> <ce:indexed-name>Carbone P.P.</ce:indexed-name> <ce:surname>Carbone</ce:surname> </author> </ref-authors> <ref-sourcetitle>Am J Clin Oncol</ref-sourcetitle> <ref-publicationyear first="1982"/> <ref-volisspag> <voliss volume="5"/> <pagerange first="649" last="655"/> </ref-volisspag> </ref-info> <ref-fulltext>Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5: 649-55.</ref-fulltext> </reference> <reference id="47"> <ref-info> <ref-title> <ref-titletext>Stabilization of mRNA Expression in Whole Blood Samples</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">18644367266</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>L.</ce:initials> <ce:indexed-name>Rainen L.</ce:indexed-name> <ce:surname>Rainen</ce:surname> </author> <author seq="2"> <ce:initials>U.</ce:initials> <ce:indexed-name>Oelmueller U.</ce:indexed-name> <ce:surname>Oelmueller</ce:surname> </author> <author seq="3"> <ce:initials>S.</ce:initials> <ce:indexed-name>Jurgensen S.</ce:indexed-name> <ce:surname>Jurgensen</ce:surname> </author> <author seq="4"> <ce:initials>R.</ce:initials> <ce:indexed-name>Wyrich R.</ce:indexed-name> <ce:surname>Wyrich</ce:surname> </author> <author seq="5"> <ce:initials>C.</ce:initials> <ce:indexed-name>Ballas C.</ce:indexed-name> <ce:surname>Ballas</ce:surname> </author> <author seq="6"> <ce:initials>J.</ce:initials> <ce:indexed-name>Schram J.</ce:indexed-name> <ce:surname>Schram</ce:surname> </author> <author seq="7"> <ce:initials>C.</ce:initials> <ce:indexed-name>Herdman C.</ce:indexed-name> <ce:surname>Herdman</ce:surname> </author> <author seq="8"> <ce:initials>D.</ce:initials> <ce:indexed-name>Bankaitis-Davis D.</ce:indexed-name> <ce:surname>Bankaitis-Davis</ce:surname> </author> <author seq="9"> <ce:initials>N.</ce:initials> <ce:indexed-name>Nicholls N.</ce:indexed-name> <ce:surname>Nicholls</ce:surname> </author> <author seq="10"> <ce:initials>D.</ce:initials> <ce:indexed-name>Trollinger D.</ce:indexed-name> <ce:surname>Trollinger</ce:surname> </author> <author seq="11"> <ce:initials>V.</ce:initials> <ce:indexed-name>Tryon V.</ce:indexed-name> <ce:surname>Tryon</ce:surname> </author> </ref-authors> <ref-sourcetitle>Clin Chem</ref-sourcetitle> <ref-publicationyear first="2002"/> <ref-volisspag> <voliss volume="48"/> <pagerange first="1883" last="1890"/> </ref-volisspag> </ref-info> <ref-fulltext>Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J, Herdman C, Bankaitis-davis D, Nicholls N, Trollinger D, Tryon V. Stabilization of mRNA Expression in Whole Blood Samples. Clin Chem. 2002; 48: 1883-90.</ref-fulltext> </reference> <reference id="48"> <ref-info> <ref-title> <ref-titletext>Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">84944174441</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>A.</ce:initials> <ce:indexed-name>Koren A.</ce:indexed-name> <ce:surname>Koren</ce:surname> </author> <author seq="2"> <ce:initials>E.</ce:initials> <ce:indexed-name>Sodja E.</ce:indexed-name> <ce:surname>Sodja</ce:surname> </author> <author seq="3"> <ce:initials>M.</ce:initials> <ce:indexed-name>Rijavec M.</ce:indexed-name> <ce:surname>Rijavec</ce:surname> </author> <author seq="4"> <ce:initials>M.</ce:initials> <ce:indexed-name>Jez M.</ce:indexed-name> <ce:surname>Jez</ce:surname> </author> <author seq="5"> <ce:initials>V.</ce:initials> <ce:indexed-name>Kovac V.</ce:indexed-name> <ce:surname>Kovac</ce:surname> </author> <author seq="6"> <ce:initials>P.</ce:initials> <ce:indexed-name>Korosec P.</ce:indexed-name> <ce:surname>Korosec</ce:surname> </author> <author seq="7"> <ce:initials>T.</ce:initials> <ce:indexed-name>Cufer T.</ce:indexed-name> <ce:surname>Cufer</ce:surname> </author> </ref-authors> <ref-sourcetitle>Cell Oncol</ref-sourcetitle> <ref-publicationyear first="2015"/> <ref-volisspag> <voliss volume="38"/> <pagerange first="387" last="395"/> </ref-volisspag> </ref-info> <ref-fulltext>Koren A, Sodja E, Rijavec M, Jez M, Kovac V, Korosec P, Cufer T. Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients. Cell Oncol. 2015; 38: 387-95.</ref-fulltext> </reference> <reference id="49"> <ref-info> <ref-title> <ref-titletext>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method</ref-titletext> </ref-title> <refd-itemidlist> <itemid idtype="SGR">0035710746</itemid> </refd-itemidlist> <ref-authors> <author seq="1"> <ce:initials>K.J.</ce:initials> <ce:indexed-name>Livak K.J.</ce:indexed-name> <ce:surname>Livak</ce:surname> </author> <author seq="2"> <ce:initials>T.D.</ce:initials> <ce:indexed-name>Schmittgen T.D.</ce:indexed-name> <ce:surname>Schmittgen</ce:surname> </author> </ref-authors> <ref-sourcetitle>Methods</ref-sourcetitle> <ref-publicationyear first="2001"/> <ref-volisspag> <voliss volume="25"/> <pagerange first="402" last="408"/> </ref-volisspag> </ref-info> <ref-fulltext>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001; 25: 402-8.</ref-fulltext> </reference> </bibliography></tail></bibrecord></item></abstracts-retrieval-response>